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ABSTRACT 
Oligodendrocytes (OLs) are the glial cells responsible for the synthesis and 
maintenance of myelin in the central nervous system. Recently, Hoxa2 was found by our 
laboratory to be expressed by OLs and down-regulated at the terminal differentiation 
stage during oligodendrogenesis in mice (Nicolay et al., 2004b). To further investigate 
the role of Hoxa2 in oligodendroglial development, a tetracycline regulated controllable 
expression system was utilized to establish two stable cell lines where the expression 
level of Hoxa2 gene could be up-regulated (CG4-SHoxa2 [sense Hoxa2]) or down-
regulated (CG4-ASHoxa2 [Antisense Hoxa2]) in CG4 glial cells. Morphologically, no 
obvious differences were observed between CG4-SHoxa2 and CG4 wild-type cells, 
whereas CG4-ASHoxa2 cells exhibited much shorter processes compared with those of 
CG4 wild-type cells. Data from BrdU uptake assays indicated that an up-regulation of 
Hoxa2 gene promoted the proliferation of CG4-SHoxa2 cells. PDGFαR (Platelet-derived 
growth factor [PDGF] receptor alpha), a receptor for the mitogen PDGF that enhances the 
survival and proliferation of OLs, was assessed at the mRNA level in both CG4 and 
CG4-SHoxa2 cells, but no significant differences were observed between Hoxa2 up-
regulated cells and wild-type CG4 cells with respect to the mRNA level of PDGFαR. In 
addition, specific investigations of the differentiation of CG4-SHoxa2 cells were carried 
out by characterizing the composition of stage specific oligodendroglial subpopulations 
in culture. Our immunocytochemical study did not indicate the differentiation course of 
the genetically engineered cells was significantly altered compared to CG4 wild-type 
cells, although results from semi-quantitative RT-PCR of oligodendrocyte-specific 
ceramide galactosyltransferase (CGT) and myelin basic protein (MBP) indicate that the 
differentiation of CG4-SHoxa2 cells was delayed when Hoxa2 gene was up-regulated. 
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I INTRODUCTION 
The vertebrate central nervous system (CNS), a highly organized complex 
structure is comprised of two fundamental cell types: neurons and glial cells. Neurons 
interconnect to establish the neuronal circuitry, facilitating electrical activity to process 
information, while glial cells are generally considered to provide physical or nutritional 
support to neurons. The two most abundant classes of CNS glia are astrocytes, which are 
important for nurturing neighboring neurons, and oligodendrocytes (OLs), which are 
responsible for myelin formation. Research interest on OLs has increased significantly in 
recent years, and has revealed that OLs play an essential role in neuronal functions, and 
are involved in processes ranging from neuron development (reviewed by Du and 
Dreyfus, 2002), to synaptic regulation (reviewed by Fields, 2005), to CNS degenerative 
diseases (reviewed in Ludwin, 1997; Compston, 2004b).  
Significant efforts have been made by researchers to provide detailed information 
on when and where OL-lineage cells originate, migrate and differentiate. In vertebrate 
brain, oligodendrocyte precursor cells (OPCs) originate from restricted ventricular 
regions (Warf et al., 1991; Noll and Miller, 1993; Levison et al., 2003) during embryonic 
development and then follow guidance cues from surrounding tissues to reach their final 
destination by long distance migration. Regulated by both intrinsic timing modulators and 
extrinsic signals from nearby environment, OPCs withdraw from cell cycling and start 
cell differentiation and maturation to give rise to myelin-producing OLs. In cultures, the 
generation of mature OLs has been well characterized, with several known cell surface 
markers (A2B5, PDGFαR [platelet-derived growth factor receptor-α], O4, GalC, and 
MBP [myelin basic protein]) and corresponding cell morphologies that depict specific 
developmental stages (Fig. 1).  
Of particular importance is to understand the transcriptional regulation during 
oligodendrogenesis, which governs the orderly gene expression that orchestrates the 
differentiation of this cell lineage. A number of transcription factors (TFs) essential for 
OL specification and maturation have been identified (Wegner, 2000; Marquardt and 
Pfaff, 2001; Gokhan et al., 2005; Wegner and Stolt, 2005; Ligon et al., 2006). For 
example, two basic helix-loop-helix (bHLH) TFs Olig1 and Olig2 are key factors that 
determine the origins of OPC, as well as their relationship to motor neurons (MNs)  
  2
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Figure 1. Schematic illustration of the developmental course of OL-lineage cells and the 
expression profiles of several transcription factors along the differentiation pathway. The 
differentiation of OLs from their progenitors follows a stepwise morphological 
transformation from bipolar appearance to multiple processes, then to a membrane-
sheath-bearing appearance. In addition to the phenotype change there is a sequential 
expression of lineage specific markers: A2B5 antigen, platelet-derived growth factor 
receptor-α (PDGFαR) in early progenitor cells, O4 antigen in late progenitor cells, GalC 
in pre-mature OLs, and myelin basic protein (MBP) in myelinating OLs. Olig1, Olig2 
and Sox 10 are expressed throughout the development of OL cells, whereas Nkx2.2 is 
only expressed during the early stages and Nkx6 homeodomain proteins are temporally 
expressed during maturation stages. Hoxa2 has been shown to be down-regulated at late 
developmental stages (Nicolay et al, 2004). The grey shaded bars indicate the temporal 
expression of the particular TF during oligodendrogenesis (Adapted from Zhang, 2001 
with permission). 
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(Takebayashi et al., 2000; Lu et al., 2000, 2002; Zhou and Anderson, 2002). TFs of the 
homeobox gene family, in particular NKx2.2, play an important role in normal 
differentiation of OLs (Qi et al., 2001; Fu et al., 2002).  
More recent studies have identified the presence of Hox genes in OL-lineage cells 
(Hao et al., 1999; Nicolay et al., 2004a, b). In vertebrates, Hox genes encode a family of 
TFs that play an critical role in determining cell identity (Trainor and Krumlauf, 2001; 
Gaufo et al., 2004), establishing body segmentation (Rijli et al., 1998; Dubrulle and 
Pourquie, 2002), modulating facial patterning (Rijli et al., 1998; Creuzet et al., 2005), 
and regulating cell proliferation and differentiation (Ford, 1998; Del Bene and Wittbrodt, 
2005). In the vertebrate hindbrain, Hox genes exhibit a highly segment-restricted 
expression profile and are believed to be crucial for specifying the identities of the 
reiterated units (rhombomeres) and the tissues originating from them (Rijli et al., 1998; 
Dubrulle and Pourquie, 2002; Creuzet et al., 2005). Particularly, in a role that resembles 
their function in regional specification, Hox genes participate in determining neuronal 
cell fates in the CNS, as well as in peripheral tissues derived from the neural crest (NC) 
(Trainor and Krumlauf, 2001; Gaufo et al., 2000,2004; Briscoe and Wilkinson, 2004). 
Furthermore, mounting evidence suggests Hox genes are also involved in directing and 
maintaining the precise projection of axons in the CNS (Gavalas et al., 1997; Arenkiel et 
al., 2003, 2004; Gaufo et al., 2004), possibly by playing key roles in both neurons and 
glial cells (Arenkiel et al., 2003, 2004). Although early development of both neurons and 
Schwann glial progenitor cells appear normal with respect to specification and cell 
population number, loss of Hoxb1 in peripheral glial cells results in incorrect projection 
of the facial nerve, likely by interfering at the later developmental stage of these glial 
cells. An additional interesting finding from Arenkiel et al.’s work (2003, 2004) is that 
the majority (over 95%) of the myelin sheaths that wrap around the axons of the facial 
nerve are derived from rhombomere 4 (r4) neural crest cells (NCCs) that also express 
Hoxb1, implying Hox genes might serve as a marker for correct contact and 
ensheathment between the neurons and Schwann cells.  
An important question that remains unresolved is whether Hox genes also 
participate in programming the fate of OLs. Nicolay et al. (2004b) conducted the first 
attempt to address this question by investigating the role of Hoxa2 gene, but no 
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substantial abnormalities of early OL specification were observed in the Hoxa2 knockout 
mice (Nicolay et al., 2004b). The seemingly unaltered expression profiles of Olig2, 
Nkx2.2 and Pax6, and the detection of O4+ve (positive) or MBP+ve OL-lineage cells are 
likely due to gene compensation for Hoxa2, since 39 Hox genes are expressed in 
vertebrate CNS, and redundancy is well known in this family (reviewed in Akin and 
Nazarali, 2005). Alternatively, the Hoxa2 gene could function at a later stage in the 
myelination process which was not considered in Nicolay et al.’s (2004b) study. 
In the brain, space restriction calls for tight organization among different types of 
cells. Hence, the regulation of cell division, cell number, as well as cell differentiation of 
OPCs is critical for the ensheathment and survival of axon bundles (Burne et al., 1996; 
Ishii et al., 2001; McTigue et al., 2001; Kotter et al., 2006). Although a coordinated 
orchestration of intracellular modulators and extracellular signals has been suggested to 
regulate the proliferation and differentiation of OL-lineage cells (Durand and Raff, 2000), 
our knowledge of the underlying mechanism(s) remains limited. Hoxa2 appears to be 
down regulated in more mature OLs that express myelin basic protein (MBP) (Nicolay et 
al., 2004b). In addition, primary OPCs isolated from Hoxa2-null mice display a 
somewhat more mature phenotype in culture than their counterpart derived from wild-
type mice (unpublished data from our laboratory). Taken together, Hoxa2 might 
participate in modulating cell-cycle and/or differentiation timing of oligodendroglial 
progenitor cells.   
To examine the potential role for Hoxa2 gene, I have used the CG4 cell line 
(Louis et al., 1992), a pure cell population with well characterized properties resembling 
oligodendrocyte-type 2-astrocyte (O-2A) in culture. An inducible expression approach 
(Tet-off) was employed to either increase or decrease the expression level of Hoxa2 
protein in CG4 cells. Once a stable expressing cell line was developed, the impact of 
over-expression of Hoxa2 gene on the proliferation and differentiation of genetically 
modified CG4 cells was examined. 
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1.1 Hypothesis 
The hypothesis to be tested is that up or down regulation of the expression level 
of Hoxa2 gene will influence the proliferation and differentiation of the genetically 
modified CG4 cells. 
1.2 Objectives 
1.2.1 To develop a tetracycline controlled Hoxa2 sense and antisense expression system, 
respectively, in the CG4 cell line 
One limitation of using Hoxa2 null mice as study model is the effect of gene 
compensation, where homologous gene products may compensate for the lost function of 
the disrupted gene and thus, obscure the function of the target gene. Additionally, Hoxa2 
gene knockout causes severe developmental defects and animals die soon after birth, 
which prevents the investigation to be carried further. Therefore, the ability to establish 
loss-of-function and gain-of-function in a controllable and inducible manner is 
particularly important and relevant so as to overcome these limitations.  
1.2.2 To examine the impact of an up-regulation of Hoxa2 gene on the proliferation and 
differentiation of CG4 cells 
Experiments carried out by Nicolay et al., (2004) employed Hoxa2 null mice as 
study subject, examining the role of Hoxa2 gene in OL-lineage cells using a loss-of-
function approach. Also, given limited time, I decided to focus on investigating the 
impact of over-expressing Hoxa2 gene on the proliferation and differentiation of OL-like 
cells. 
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II LITERATURE REVIEW 
2.1 Oligodendrogenesis 
Astrocytes, microglia and OLs are commonly known as glial cells, and constitute 
the majority of the cell population in the central nervous system (CNS) of the vertebrates. 
OLs form the fatty sheath surrounding nerve fibres known as myelin. Accumulating 
evidence indicates that myelin plays a key role in the structure, function and maintenance 
of axons, providing essential growth factors (Byravan et al., 1994; Dai et al., 1997; 
Raabe et al., 1997) and guidance cues (Kuhn et al., 1999; Sandvig et al., 2004; Goldberg 
et al., 2004). Damage of myelin via X-irradiation (Colello et al., 1994), pathological 
attack (Martin et al., 1992) or genetic instability (Jacobs, 2005) can lead to severe neural 
degeneration, functional deficits, or animal lethality. As a result, significant efforts are 
being taken to explore the many biological aspects of oligodendrogenesis, and to identify 
the underlying mechanisms that modulate the developmental course of the OL-lineage 
cells, aiming to develop potential therapeutic approaches for myelin related neural 
disorders.  
Mature OLs are derived from highly mitotic and migratory precursor cells (OPCs), 
which undergo a sequential process of cell development. This embryonic advancement 
entails a complex combination of events established through a program of gene 
expression and controlled by master transcriptional regulators. I provide below a review 
of the transcriptional mechanisms controlling the cell cycle progression, cell growth, and 
differentiation of OL-lineage cells, with specific focus on understanding the potential role 
of Hox genes in these processes.  
2.1.1 Stepwise development of OL-lineage cells 
Progress in morphological techniques and the discovery of cellular markers by 
immunocytochemical techniques have greatly expanded our knowledge of OL-lineage 
cells. OL cells are morphologically distinguishable from other glial cells, possessing 
ample amount of microtubules in their extending processes, but lacking in intermediate 
filaments and glycogen (Peters et al., 1991; Baumann and Pham-Dinh, 2001). In addition, 
extending from the cell body of a myelinating OL are a variable number of processes, 
which contact and repeatedly envelop 1-2 mm segments of as many as 40 different axons 
during early postnatal development in rodents (Bray et al., 1981; Fanarraga et al., 1998).  
  8
Prior to maturation and myelin formation, OL-lineage cells undergo a series of 
phenotypic stages of development, characterized by the expression of distinct profiles of 
antigenic markers (Fig.1), as well as a change in their mitotic and migratory status 
(reviewed in Zhang, 2001; Miller, 2002). In culture, the OL lineage has been 
subcategorized into 4 stages: progenitors (A2B5+), pre-oligodendrocytes (late 
progenitors, O4+), pre-myelinating (immature, GalC+) oligodendrocytes and myelinating 
(mature, MBP+) oligodendrocytes (Woodruff et al., 2001; Zhang, 2001; Miller, 2002). 
OPCs are also known as oligodendrocyte-type 2-astrocyte (O-2A) cells, because they can 
differentiate into both OLs and type 2 astrocytes depending on the culture medium (Raff 
et al., 1984). OPCs are highly mitotic and migratory, featuring cell surface markers that 
include A2B5 and platelet derived growth factor receptor alpha (PDGFαR) (Raff, 1989). 
Late-progenitor cells retain their mitotic ability, and gradually lose anti-A2B5 antibody 
reactivity, while they begin to express the antigen recognized by the O4 monoclonal 
antibody (Pfeiffer et al., 1993). Upon reaching the target destination, single OL cells 
become postmitotic and start to express galactocerebroside (GalC or O1 antigen) on their 
surface. At this stage, non-myelinating OLs have an extremely dense network of 
processes that contain primary (emerging from the cell body), secondary (branched on 
the primary process), and tertiary (interconnecting primary and secondary filaments) 
outgrowths. Eventually, myelinating OLs are defined by the expression of myelin-
specific proteins, including myelin basic protein (MBP), myelin proteolipid protein (PLP), 
and myelin oligodendrocyte glycoprotein (MOG) (Baumann and Pham-Dinh, 2001; Le 
Bras et al., 2005). In comparison to the non-myelinating stage, the morphology of a 
myelinating OL is dramatically altered. The myelinating OLs have less primary and 
secondary processes, no tertiary processes, but bear whorls of myelin-like structures at 
their tips (Fig. 1). 
In summary, throughout the maturational stages of an OL, a number of cell 
lineage specific markers are sequentially expressed as others are lost. The well defined 
profile of stage-specific cell surface markers has allowed the progressive differentiation 
and maturation of OL-lineage cells to be followed, providing insights into particular 
functions carried out by these cells.  
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Given that the orderly changes of gene expression are under the coordination of 
signaling molecules and cell intrinsic transcription factors (TFs), elucidating the 
transcriptional control cascade that governs the development of oligodendroglial cells has 
been of considerable interest. In this context, several families of TFs that are essential for 
the generation, specification and maturation of OLs have been identified, in  particular 
the homeodomain (HD) protein family (Nkx2.2, Nkx6.1, Nkx6.2, Hoxa2, Hoxb1), the 
zinc finger protein family (Olig1, Olig2, Id2, Id4) and the HMG-domain protein family 
(Sox10) (reviewed in Wegner, 2000; Zhou et al., 2000; Qi et al., 2001; Zhou and 
Anderson, 2002; Wei et al., 2004, 2005). Notably, research suggests some of these 
known TFs, including Olig1, Olig2 and Sox10, are restricted to OL-committed cells in 
the CNS (Kuhlbrodt et al., 1998; Zhou et al., 2000), and thus these TFs are frequently 
utilized in research as OL cell lineage markers.  
2.1.2 Generation and specification of OL-lineage committed precursors 
Glial cells and neurons are both derived from multipotent neural stem cells (NSC) 
(Wu et al., 2006), but the intermediate steps that NSCs follow to generate the OL-lineage 
cells are still undetermined. Based on in vivo and in vitro studies, models of different 
lineage perspectives have been proposed for the genesis of oligodendrocytes (reviewed in 
Anderson, 2001; Stiles, 2003). All of these models agree that some known TFs, such as 
Olig1, Olig2, and Nkx2.2, mediate the switch from intermediate progenitors to OPCs.  
2.1.2.1 Dorsal-ventral debate of oligodendrocyte precursor cell origin 
Mature OLs that disperse widely in the white matter of the CNS are derived from 
highly proliferative and mobile progenitors, the origins of which have been extensively 
discussed and examined (Warf et al., 1991; Pringle and Richardson, 1993; Fok-Seang 
and Miller, 1994; Hall et al., 1996; Hardy and Friedrich, 1996; Birling and Price, 1998; 
Tekki-Kessaris et al., 2001). With the recent discovery of cell-lineage specific markers 
and increasing understanding of the transcriptional patterning in the developing neural 
tube, researchers have been able to locate the birth place of OPCs (Fig. 2).  
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Figure 2. The embryonic spinal cord is divided into various domains that give rise to 
specific neural progenitor cell types. Several homeodomain (HD) families of proteins 
were identified in the spinal cord, the expression profiles of which are featured with a 
regional-restricted characteristic associated with sonic hedgehog (Shh) signalling. The 
cell types generated from each domain are indicated on the left. Transcription factors 
belonging to the Class I factors are repressed by Shh, and are indicated in green on the 
right. The expression patterns of Class II factors are depicted in red on the right. P1–dP6, 
dorsal progenitor domains; pMN and p0-p3, ventral progenitor domains; Olig2, 
oligodendrocyte lineage gene 2; Pax6,7, paired box gene 6,7; Dbx1,2, developing brain 
homeobox 1,2; Irx3, iroquois homeobox protein 3 (Modified from Richardson et al., 
2006).   
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One of the best studied systems of neural patterning is the embryonic spinal cord, 
where regional restricted expression profiles of particular TFs have been depicted (Fig. 2) 
(Reviewed by Woodruff et al., 2001; Kessaris et al., 2001; Marquardt and Pfaff, 2001; 
Richardson et al., 2006). During early neurogenesis, a gradient of the morphogen sonic 
hedgehog (Shh), emanating from notochord and floor plate, set up the expression of two 
classes of patterning cues. Class I molecules, including Pax6, Dbx1 and Irx3, are 
repressed by Shh, whereas the expression of Class II members, Nkx2.2, Nkx6.1 and 
Olig1/2 requires Shh (Briscoe et al., 2000; Briscoe and Ericson, 2001). In addition, these 
TFs exhibit a nested pattern of expression in the spinal cord, partitioning the ventricular 
zone of the spinal cord into 5 progenitor domains, namely p0, p1, p2, pMN and p3, 
respectively (Fig. 2) (Briscoe et al., 2000; Jessell, 2000). Intriguingly, all of the 
patterning molecules, with the possible exception of Olig2, are homeodomain TFs, and 
they likely function as transcriptional repressors (Jessell, 2000). Since the appearance of 
Olig2 and PDGFαR expressing cells are first seen in the pMN domain (Pringle and 
Richardson, 1993; Hall et al., 1996), and dorsally derived E14 neuroepithelium cells are 
unable to generate GalC+ve cells after 9 days in vitro (Warf et al., 1991), it has been 
suggested that OPCs originate only from a restricted ventral region (pMN) and 
subsequently migrate to colonize the whole spinal cord. 
Instead of employing the usual in vitro approach, embryologists have used chick-
quail chimeras to assess whether the dorsal regions of the spinal cord are able to generate 
OPCs (Cameron-Curry and Le Douarin, 1995; Pringle et al., 1998). However, 
inconsistent results were obtained from these chimeric studies, which might be due to the 
variation in dissecting techniques between different research laboratories. Interestingly, 
recently published articles have provided convincing evidence supporting multiple 
origins, including a dorsal birthplace, for OL-lineage cells in the spinal cord (Hardy et al., 
1996; Soula et al., 2001; Fu et al., 2002; Gregori et al., 2002; Cai et al., 2005; Vallstedt 
et al., 2005; Richardson et al., 2006). In particular, Cai et al. (2005) show dorsal 
oligodendrogenesis exists in Nkx6.1/Nkx6.2 and Shh mutant mice, where the early 
generation of OPCs at the pMN domain is diminished and the possibility of ventral-
dorsal migration of OPCs is eliminated. Most importantly, Cai et al. (2005) demonstrate 
the expression of Pax7 and Mash1 in these dorsally derived Olig2+ve cells in vitro, thus 
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overcoming the argument that the dorsal cells might have undergone a ventral fate switch 
in Nkx6 mutant mice. Consistent with these findings, Vallstedt et al. (2005) found 
dorsally derived OPCs do not express Nkx2.2 but Pax7, and vice versa for the ventral 
OPC counterpart (Fig. 3).  
In the ventral zone of the spinal cord, an independent population of OPCs derived 
from the p3 domain has been reported in addition to the group of OPCs from the pMN 
domain (Soula et al., 2001; Zhou et al., 2001; Fu et al., 2002). The p3 domain features 
the expression of Nkx2.2, which sets the ventral limit of Olig2, or the pMN domain, 
during neurogenesis (Fig. 2). Upon completion of neuron generation, the boundary 
between p3 and pMN no longer exists, and Olig2 and Nkx2.2 are co-expressed with the 
onset of oligodendrogenesis. However, double immunolabelling techniques have revealed 
two distinct populations of OPCs that originate from the pMN and p3 domains, 
respectively, where the pMN region gives rise to Olig2+ve/Nkx2.2-ve OPCs and the p3 
gives rise to Nkx2.2+ve/Olig2-ve progenitors (Fig. 3) (Zhou et al., 2001; Fu et al., 2002).  
Taken together, the above findings indicate multiple sources of OPCs in the spinal 
cord, although the onset of a specific progenitor population begins at a defined embryonic 
stage (Fig. 3). It has therefore been proposed that the emergence of different pools of 
OPCs might be under the control of regional signals and this is probably associated with 
their later functions (Miller, 2005). This interpretation of the findings also sheds new 
light on how these regionally dominated HD proteins participate in oligodendrogenesis. 
The cross-repressive interactions between Class I and Class II proteins likely establish the 
dorsal-ventral (D-V) identity of the early domestic OPCs and may play a role in initiating 
the timing of OPC generation, as this D-V organization of cell subtype specification in 
the spinal cord has clearly been demonstrated in the spatial patterning of neurons 
(Lumsden and Krumlauf, 1996; Pattyn et al., 2003).  
2.1.2.2 OPCs are generated along the rostrocaudal axis of the embryonic brain 
The battle of ideas on the dorsal origin of OPCs, however, overshadows another 
dimension of the developing neural tube - the anterior-posterior (A-P) axis. Are tissues 
along the A-P axis all able to produce OPCs? Although studies of this A-P distribution of 
OPCs within CNS remain rare, several lines of evidence demonstrate that progenitor cells 
can be generated along the rostrocaudal axis in both mouse and chick (Hardy and  
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Figure 3. Ventral and dorsal sources of Olig2+ve cells. At least three independent 
sources have been suggested in the spinal cord. At E15 in mice, a few Olig2+ve cells start 
to originate from the Pax7 and Gsh1 patterned dorsal region (red rectangular) (Cai et al., 
2005; Vallstedt et al., 2005). The dorsally derived Olig1/2+ve cells express other OL-
lineage markers, including PDGFαR, Sox10 and NG2, but not Nkx2.2. The dorsally 
obtained OPCs progress to MBP expressing oligodendrocytes well after birth (Vallstedt 
et al., 2005). Further, in the ventricular region of the spinal cord, OPCs can be generated 
from both the pMN domain and p3 domain (Fu et al., 2002; Zhou et al., 2001). At the 
early stages of oligodendrogenesis, before the dorsal expansion of the Nkx2.2 expressing 
domain, the Olig2+ve cells arise and initially do not express Nkx2.2; vice versa for cells 
that originate from the p3 region (Based on Figure 4Y from Vallstedt et al., 2005). 
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Friedrich, 1996; Olivier et al., 2001; Vallstedt et al., 2005; Le Bras et al., 2005) in the 
hindbrain and spinal cord. Tissues of all regions along the A-P axis in the CNS, including 
coronal slices of hindbrain, cervical, and lumbar spinal cord, as well as the dorsal 
telencephalon of embryonic mice (E10.5-E12.5), were transplanted into the left cerebral 
hemisphere of postnatal mice, at the level of the subcortical white matter (Hardy and 
Friedrich, 1996). Unexpectedly, all of these regions taken from E10.5 mice, prior to any 
expression of putative OPC markers, gave rise to MBP+ve cells following transplantation. 
In addition, Le Bras (2005) and Hardy (1996), respectively, show that at least along the 
A-P axis of the hindbrain, there are discrete expression foci of the markers PLP in chick 
and O1 in mouse.  
By using immature OL markers, O1 and R-mAb (Ranscht monoclonal antibody, 
Ranscht et al., 1982), the stage specific maps of differentiated oligodendrocytes were 
depicted (Hardy and Friedrich, 1996). At E14.5, immunostained positive cells were first 
observed along the midline of the posterior hindbrain and at the restricted ventral region 
of anterior hindbrain. In contrast, the first appearance of O1+ve cells is detected from the 
posterior forebrain at E18.5, whereas in the anterior forebrain they are observed after 
birth. From these observations, the first conclusion of Hardy and Friedrich (1996) was 
that two discontinuous groups of OLs exist in the brain: one caudal group in the spinal 
cord, hindbrain and midbrain; and a rostral group in the anterior diencephalon and the 
telencephalon. Furthermore, they suggested that the maturation of OPCs starts 
caudorostrally within the CNS, indicating OLs might also have spatial programmed 
identity along the A-P axis of the neural tube, a theory which is supported by several 
other research groups (Fanarraga et al., 1998; Spassky et al., 1998; Olivier et al., 2001).  
Olivier et al. (2001) used the quail-chick chimeras to address the question of 
whether OPCs developed metamerically in the hindbrain, as observed in many other cell 
types (reviewed by Rijli et al., 1998; Lumsden, 2004). In fact, discrete populations of 
OLs are compartmentalized within the caudal hindbrain by inter-rhombomeric 
boundaries (Figure 4A) (Hardy and Friedrich, 1996). Additionally, the migration and 
myelination of the OPCs derived from each rhombomere (r) remains confined within the 
compartment (Figure 4B) (Olivier et al., 2001). Yet, it is not clear if this spatial position 
identity is correlated with their myelination of axons in a specific region, since optic  
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Figure 4. Compartments of oligodendrocytes within the hindbrain rhombomeric 
segments. A. Pre-mature OLs were recognized using O1 antibody, and displayed 
regionally restricted patterns, corresponding to each rhombomeric unit (Hardy and 
Friedrich, 1996). B. Specific migration routes of independent oligodendrocyte 
populations along the anterior-posterior axis in the CNS (Olivier et al., 2001). r1-r8, 
rhombomere1-8; p1-p6, prosomere1-6; sc, spinal cord; ZL1, zona limitans intrathalamica; 
ET, eminentia thalami; I, Isthmus; AEP, anterior entopeduncular area; M, mesencephalon; 
MGE, medial ganglionic eminence. Images are taken from Hardy and Friedrich (1996) 
and Olivier et al. (2001) with permission.  
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nerve derived OLs are able to myelinate axons in the spinal cord (Fanarraga et al., 1998). 
It is very likely that under normal conditions OPCs are generated at multiple foci and 
follow specific radial or tangential migration paths within a small coronal slice of tissue 
to ensure efficient myelination of the sophisticated neural network. On the other hand, 
regional OPCs or late-progenitors could have the capacity to migrate and myelinate axons 
in other regions, or in cultures, so that damage (e.g. demyelination) can be repaired 
quickly. However, it will be interesting to explore the molecular mechanisms that 
constrain their radial migrations within the confined segments along the A-P axis of the 
neural tube.     
2.1.2.3 Commitment of OL-lineage cells 
In the developing rodent spinal cord, expressions of early OL marker genes, such 
as Olig2, PDGFαR and Sox 10, are first detected in the pMN domain, where this same 
region gives rise to the MNs at an earlier stage (Sun et al., 2001; Lu et al., 2002; Zhou et 
al., 2001; Fu et al., 2002). Thus, MNs and OLs are believed to be sequentially generated 
from the same precursor cells at different time windows (Richardson et al., 1997, 2000). 
However, the controversy about the relationship between neurons and OLs was 
compounded by the finding of glial restricted precursors (GRPs) in primary cell cultures 
derived from different parts of the spinal cord (Rao et al., 1998; reviewed in Liu and Rao, 
2003), which gave rise to the hypothesis that OL-committed progenitor cells come from 
lineage restricted precursors. As a result, multiple types of intermediate glial precursors 
were proposed and various models of neural cell lineage relationships were described 
(Richardson et al., 2000; Rowitch et al., 2002; Liu and Rao, 2003). 
Regardless of the model debate, two bHLH transcriptional factors - Olig1 and 
Olig2 - have been conclusively found to play a key role in the neuronal switch and OL 
specification (Lu et al., 2000; Nery et al., 2001; Takebayashi et al., 2002; Zhou and 
Anderson, 2002; Lu et al., 2002). In Olig1/2 double-mutant mice, MNs and OL are 
largely eliminated, whereas V2 interneurons and astrocytes are produced from the pMN 
region (Zhou and Anderson, 2002). Additional evidence indicates Olig1 and Olig2, 
respectively, exhibit different expression profiles within the CNS (Takebayashi et al., 
2000), indicating they do not simply compensate each other but may participate in 
different embryonic events in various cell types. Consistent findings from a loss of 
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function study suggest that Olig1 is dispensable for OPC formation, but is required for 
terminal maturation and proper myelination of OLs (Lu et al., 2000, 2002; Xin et al., 
2005). In contrast, Olig2-null animals fail to produce OPCs in the spinal cord, although 
small patches of OPCs in the forebrain and relatively normal numbers of PDGFαR+ve 
cells in the hindbrain were reported (Lu et al., 2002). Taken together the proposed 
multiple origins for oligodendrogenesis in the CNS, OPCs originating from different 
regions might be under the control of local mechanisms rather than under one global 
regulatory mechanism.  
Sonic Hedgehog is a potent inducer and is obligatory for OL generation in both 
rostral and caudal neural tube (Orentas et al., 1999; Nery et al., 2001; Tekki-Kessaris et 
al., 2001). Knocking down Shh signalling results in the absence of OPCs at normal 
embryonic stages; conversely, ectopic OPCs can be induced in dorsal loci by Shh. At 
least part of the pro-oligodendrocyte function of Shh can be attributed to its temporal-
specific regulation of Olig (Olig1 and Olig2) genes (Lu et al., 2000; Nery et al., 2001; 
Cai et al., 2005). Unlike Shh, members of the bone morphogenetic proteins (BMPs) have 
been proposed as inhibitors of OL fate even in the presence of Shh, possibly by 
repressing the transcription of olig genes (Gross et al., 1996; Mekki-Dauriac et al., 2002). 
From a neural patterning point of view, the antagonistic roles played by Shh and BMP 
can be attributed to their activity gradient patterns along the D-V axis of the neural tube 
(Jessell, 2000).   
A cell intrinsic timing control mechanism has also been proposed, where Neural 
Stem Cells (NSCs) orderly generate neurons and various types of glial cells by counting 
time and/or cell division (Ibarrola et al., 1996). Suggestions for the identity of the internal 
timer include telomere length, the cyclin-dependent kinase inhibitor p27, and receptors 
for epidermal growth factor (EGF) and fibroblast growth factor (FGF) (Morrison, 2000). 
Lastly, an intermediate hypothesis proposes the interplay between extrinsic local signals, 
including Shh, BMP, and Notch, and cell intrinsic cues determines the emergence of 
spatially distributed OPCs (Fig.2) (Billon et al., 2002b), particularly in the cell fate 
decisions of retinal cells (reviewed by Cepko, 1999).  
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2.1.2.4 Homogeneity vs. heterogeneity in OPCs 
Morphologically, four types of mature OLs have been reported (Bjartmar et al., 
1994). We are accustomed to thinking of OPCs as a functionally homogenous population, 
which, in fact, might not be the case, as increasing evidence suggests. For example, OPCs 
isolated from different brain regions exhibit distinct properties in terms of maturation 
timing and responsiveness to thyroid hormone (TH) (Power et al., 2002). However, this 
discrepancy might be due to OPCs undergoing various cycling programs while migrating 
to reach their destination in the CNS, rather than due to inherent differences.  
However, two recent studies provide strong evidence of a dorsal origin of OPCs, 
demonstrating the TF profiles of the dorsal pool of Olig2+ve cells are distinguishable 
from that of their ventral counterpart (Cai et al., 2005; Vallstedt et al., 2005). Kitada and 
Rowitch (2006), with the aid of new fluorescent technique and confocal microscopy, 
dissected the expression patterns of several TFs (Olig1, Olig2, Nkx2.2 and Sox10) in 
both adult OPCs and mature OLs, revealing that various combinations of these four 
molecules exist within subpopulations of OL-lineage cells. In particular, a co-localization 
study of Olig1 and Olig2 indicated a distinct cytoplasmic distribution of Olig1 in stage 
specific OLs.  
More intriguingly, several lines of evidence from the study of Olig2 (Lu et al., 
2002) and Nkx6.1 (Liu et al., 2003; Vallstedt et al., 2005) imply heterogeneity in 
oligodendrogenesis also occurs along the A-P axis. Along with the fact that OL-lineage 
cells are generated along the A-P body axis, it is therefore important to see if mature OLs 
also bear spatial identity corresponding to the regions they are derived from, as observed 
in neurons whose identity is regulated by regional signals, or ‘Hox genes’, in the 
hindbrain. Although TF heterogeneity of OL-lineage cells is described, how these 
expression patterns regulate cellular function has not been established. Further 
investigations are necessary to determine whether TF expression profiles correlate with 
the morphology and function specificity of OLs in distinct regions of the CNS.  
2.1.3 Differentiation and maturation of OPCs 
Once committed to the OL lineage, precursors undergo a massive but specific 
pattern of migration to colonize the entire CNS (Olivier et al., 2001). These migrating 
progenitors actively proliferate and respond to growth factors such as PDGF and FGF 
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(Raff et al., 1989; Richardson et al., 1988). After dividing a limited number of times, 
OPCs transform into pre-myelinating OLs, and stop at their defined destination. As 
differentiation progresses, newly formed immature OLs start to produce GalC but lose 
the expression of O4. Finally, the synthesis of 2', 3'-Cyclic nucleotide 3'-
phosphodiesterase (CNPase) demarks the onset of terminal maturation, whereas MBP is 
expressed 2-3 days later along with PLP (Barradas et al., 1995; Reynolds and Wilkin, 
1988), immediately before myelin formation. Significant efforts have been directed at 
discovering the cellular and molecular cues that control this sophisticated schedule of 
development.  
Terminal differentiation of OLs is a carefully orchestrated event in vivo to ensure 
timely myelination of the axons. Both cell intrinsic timing mechanisms (reviewed in Raff 
et al., 1998; Durand and Raff, 2000) and extracellular mitogenic factors, including PDGF 
(Raff et al., 1998; Richardson et al., 1988) and thyroid hormone (Rodriguez-Pena, 1999; 
Billon et al., 2002a), have been proposed to play a role in the regulation of the 
differentiation and maturation of OLs.  
2.1.3.1 Mitogenic factors influence the development of oligodendrocytes 
A number of soluble factors can regulate the proliferation and differentiation of 
OLs in vivo and in vitro, and one major player appears to be PDGF (Richardson et al., 
1988; Raff et al., 1998; Calver et al., 1998).  In culture, PDGF is able to inhibit 
premature differentiation and restore the development of isolated O-2A cells as in their in 
vivo counterparts (Raff et al., 1989). In mice where the PDGF-A gene has been 
inactivated, severe reduction of OPCs and mature OLs, along with a dysmyelinating 
phenotype, were reported (Fruttiger et al., 1999). Recently, Baron and co-workers (2002) 
have further demonstrated that PDGF promotes the proliferation of OPCs by activation of 
αvβ3 integrin in the extracellular matrix (ECM), which in turn induces OPC proliferation 
via a phosphatidylinositol 3-kinase-dependent signalling pathway. In addition to PDGF, 
fibroblast growth factor-2 (FGF-2) and insulin-like growth factor 1 (IGF-1) also have 
been shown to enhance the proliferation of OPCs in cultures. 
The story does not end here, since in PDGF containing cultures O-2A precursor 
cells keep on differentiating, corresponding to their normal development timeline. 
Addition of excess PDGF does not alter the timing of OL development, and newly 
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formed OLs continue to express large amounts of PDGFαR, thus excluding the 
possibility of PDGF signalling blockage (Temple and Raff, 1986). This finding raised the 
possibility that the progenitor cells have a cell-intrinsic mechanism which governs their 
proliferative capacity and controls when they should withdraw from the cell cycle and 
start terminal differentiation. In support of this concept, Gao et al. (1997) demonstrated 
that purified embryonic OPCs underwent the same developmental course as their in vivo 
counterparts, even when the cells were maintained in a relatively constant environment 
and in the virtual absence of other cell types.  
2.1.3.2 The role of thyroid hormone  
Another important factor that regulates OL development is thyroid hormone (TH). 
Hypothyroidism in rat increases proliferation of NG2+ve cells in the subventricular zone 
(SVZ) and delays the differentiation of OPCs (Fernandez et al., 2004). In contrast, 
enhanced TH levels exert opposite effects on OL-lineage cells. In cultures containing 
mitogens (PDGF, FGF) and TH, OPCs develop on time (Gao et al., 1998), whereas very 
few precursors display a more advanced morphology if TH (T3 and T4) is omitted from 
this defined medium (Barres et al., 1994). Furthermore, several independent studies 
confirm that thyroid hormone receptors are expressed on both OPCs and OLs (Barres et 
al., 1994; Gao et al., 1998), implying TH directly regulates OL-lineage cells.  Retinoic 
acid (RA) has been shown to have the same impact on OL-lineage cells as TH (Barres et 
al., 1994).  
Surprisingly, OPCs purified at different developmental stages react differently to 
TH. P7 precursor cells stop dividing and differentiate rapidly in the presence of T3, 
whereas E18 progenitor cells remain in cell cycle until 3-4 days later in cultures with T3 
(Gao et al., 1998). However, when cells are cultured in medium without any mitogens 
(PDGF, FGF etc.), no obvious difference is observed in the morphology or rate of 
advancement in cell groups treated with or without TH within a 2-day examination period 
(Barres et al., 1994). Based on above findings, it was concluded that TH does not trigger 
differentiation, but rather it activates the effector component of the built-in timer of OL-
lineage cells to overcome the influence of mitogens, which have to be persistently 
produced in vivo to promote OL survival.    
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2.1.3.3 Transcriptional regulations for an intrinsic timing clock  
Abundant evidence from the study of mitogens and hydrophobic signals indicates 
an internal circadian system exists and masters the development of OLs (Temple and 
Raff, 1985, 1986; Barres et al., 1994; Gao et al., 1997, 1998).  Specifically, two 
components have been described for this timing mechanism: (1) a timing mechanism that 
might depend on PDGF or other growth factors to measure elapsed time, and (2) an 
effector element, which is regulated by TH or other signals, to initiate cell differentiation 
when the time is up.  
It is conventionally believed that such a timer should interact with cell cycling in 
counting the elapsed time. Therefore, proteins including cyclins or Cdks (cyclin-
dependent protein kinases) that normally drive the cycling machine and molecules that 
suppress cell-cycle operation, like p27/Kip1, were carefully examined. Although 
accumulated data suggest p27/Kip1 participates in the timing event (Durand et al., 1997), 
the puzzle is far from solved. Therefore, researchers have focused on the transcriptional 
control of OL-lineage cells which govern the sequential expression of key genes during 
cell commitment and differentiation, in attempts to determine the timing regulation.  
Available evidence strongly suggests that the Notch pathway plays a critical role 
in the differentiation of OL-lineage cells (reviewed by Wang and Barres, 2000). In the rat 
optic nerve system, Notch1 is expressed in OPCs while Jagged, a Notch ligand is present 
on the optic nerves (Wang et al., 1998). Activation of Notch1 by Jagged can powerfully 
inhibit the differentiation of OPCs in culture (Wang et al., 1998). Moreover, the 
expression of Jagged on optic nerves is controlled developmentally in vivo such that 
Jagged levels decrease while embryonic development progresses, thus allowing 
myelination to occur in a controlled manner (Wang et al., 1998). Additionally, Notch 
activation generally leads to the expression of Hes family inhibitory basic helix-loop-
helix TFs (Kageyama and Nakanishi, 1997). The expression of one Hes family member, 
Hes5, was found in optic nerve OPCs. Ectopic expression of Hes5 can block the 
differentiation of OPCs in culture (Kondo and Raff, 2000), indicating Notch1 might act 
through Hes5 to inhibit the terminal differentiation of OL-lineage cells in the optic nerve. 
Id2, another inhibitory bHLH factor, was also found to negatively regulate OPC 
differentiation (Wang et al., 2001). As both Hes and Id family bHLH factors are known 
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to antagonize the functions of tissue specific bHLH transcription factors (Kageyama and 
Nakanishi, 1997), it was hypothesized that unknown E-box bHLH factors might 
positively promote the terminal differentiation of OPCs (Kondo and Raff, 2000; Wang et 
al., 2001). Whether the candidates might be Olig1 and/or Olig2 remains to be determined, 
although Gokhan (2005) shows the combination of Sox10, E47 and Olig2 can greatly 
enhance MBP promoter activity. Moreover, the above findings are mostly based from 
observations in culture or using optic nerve as the in vivo model system. In the spinal 
cord and brain, Notch receptors and ligands, Hes and Id family members are expressed in 
complicated patterns (Kageyama and Nakanishi, 1997; Artavanis-Tsakonas et al., 1999; 
Andres-Barquin et al., 2000), and are not specific to the OL-lineage cells. Whether some 
or all of them participate in controlling the timing of myelination in distinct brain regions 
is yet to be elucidated.  
In addition to the Id proteins, Sox10 (Wei et al., 2004; Gokhan et al., 2005) and 
Nkx2.2 (Wei et al., 2005; Gokhan et al., 2005), two crucial TFs during OPC early 
specification and commitment, have also been suggested as important for the normal 
timing of differentiation. In particular, Gokhan et al. (2005) revealed a transient down-
regulation of Nkx2.2 in early OL progenitor cells (NG2+ve/O4+ve), followed by a 
transient up-regulation of this TF in more advanced progenitor cells (NG2-ve/O4+ve, 
GalC+ve/O1+ve) before terminal differentiation. The second wave of expression of 
Nkx2.2 indicates two distinct roles for this gene at different developmental stages, but 
with one ultimate goal - to regulate the expression of myelin proteins and the onset of 
maturation program at the right time (Watanabe et al., 2004). Consistent with this 
suggestion, Qi et al. (2001) found that the appearance of MBP and PLP/DM20 are 
severely reduced and delayed in Nkx2.2 null animals. This retarded differentiation does 
not appear to be due to the delay of early OPC specification, since Olig1/Olig2 double 
positive cells and PDGFαR+ve cells are observed at normal developmental stages. Thus, 
homeodomain-containing protein Nkx2.2 may directly regulate the expression of myelin 
protein encoding genes, supported by the findings reported by Wei et al., (2005) that two 
regulatory elements in the promoter of mbp interact with Nkx2.2 in vitro. 
Another transcription factor, CREB (cyclic AMP response element binding 
protein) has been demonstrated to play a role during the final differentiation of OLs 
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(Sato-Bigbee et al., 1999; Afshari et al., 2001). CREB regulation and its downstream 
molecular signalling pathways are under extensive investigation (Sato-Bigbee et al., 
1999). Several laboratories have shown that OL differentiation is stimulated by cyclic 
adenosine monophosphate (cAMP) (Raible and McMorris, 1989), while Montminy et al. 
(1990) demonstrated that the expression of cAMP is under the transcriptional control of 
CREB. Interestingly, elevated expression of CREB immediately precedes the peak in 
myelin synthesis (Sato-Bigbee et al., 1994). Recently, Garcia et al. (2004) provided more 
convincing evidence that this cAMP/CREB mediated pathway can induce exit from cell 
cycling by increasing p27/Kip1 levels and diminishing cyclin D1 expression at a specific 
stage during oligodendrogenesis. In fact, CREB phosphorylation is required for CREB-
mediated transcription. Shiga et al. (2005a, b) report this phosphorylation is principally 
regulated by protein kinases A (PKA) in the progression from OPCs to late-progenitor, 
but by protein kinases C (PKC) in subsequent differentiation to mature OLs. Therefore, 
studying this phosphorylation serves to identify events upstream of CREB, and help to 
advance our understanding of how mitogen stimulations are connected to cytoplasmic 
event cascades. 
The impact of THs on the maturation of OLs are known to be mediated by 
specific thyroid hormone receptors (TRs), which are ligand-activated transcription factors 
that modulate the expression of certain down stream targets. Three of these receptors - α1, 
β1, and β2 - are expressed in OL-lineage cells, with α1 found only in progenitor cells and 
β1 mostly present in mature OLs, suggesting specific functions for both types of TRs 
during the development of OL-lineage cells. Furthermore, Billon et al. (2002a) propose 
TR α1 might be associated with the timing of cell differentiation, since OPCs derived 
from TR α1 -/- mouse fail to differentiate in response to TH. The transcriptional 
regulation of thyroid hormone-receptor is likely to directly interact with the MBP 
promoter region, as has been demonstrated by Farsetti et al. (1991).  
Importantly, this circadian clock is based on the interconnections of various TFs, 
which via positive and/or negative feedback loops may mediate the pace and function of 
the clock. To fully illustrate this internal timing mechanism in OL-lineage cells, in 
addition to identifying factors that participate in this event, further investigations of the 
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relationships within this transcriptional arch, as well as how the TF cascades associate 
with cellular behavior and physiology will be needed.  
2.1.3.4 Proliferation and differentiation of OPCs contribute to cell number control  
The number of cell divisions and the timing of cell differentiation onset are 
controlled tightly, not only for myelinating axons in a timely manner but also for the 
regulation of the population size of mature OLs (Barres and Raff, 1994; Casaccia-
Bonnefil et al., 1997; Raff et al., 1998). The population size of OL-lineage cells in a 
specific region must be generated and maintained properly so that they match the number 
and length of axons, allowing the correct establishment and function of the CNS. For 
example, lack of a sufficient number of OLs often results in loss of nearby axons, as 
revealed by many demyelinating and degenerative neural diseases (reviewed in 
Compston, 2004a). In general, the quantity of cells depends on the orchestration of the 
duration of cell division, timing of cell differentiation and cell death. As summarized 
above, cell proliferation and the onset of differentiation as well as the regulation of cell 
numbers are regulated by cell autonomous intracellular timing program, which interplays 
with dynamic extracellular signals. Extracellular signals, such as PDGF, TH, RA and 
Notch1 pathway have been demonstrated as effectors in regulating the proliferation and 
the maturation of OL-lineage cells. The internal mechanisms that regulate cell cycle 
machinery involve a tissue specific transcriptional system, which may directly modulate 
components within this timing system and/or interact with mitogen pathways that drive 
the G1 progression. In neuron progenitors, knock out of Pax6, a homeodomain TF, has 
been shown to interrupt cell-cycle kinetics in mice cortex, resulting in a large increase in 
the length of S phase and extension of the overall cell cycle (Warren et al., 1999; Estivill-
Torrus et al., 2002). During oligodendrogenesis, the TF Sox10 has been shown to 
activate the promoter of MBP, at least partially via regulating the expression of a 
secondary transcription factor Sp1 (Wei et al., 2004). In parallel the up-regulation of Sp1 
results in an elevation of p27/Kip1, an inhibitor of the cell cycling system in OLs. 
2.1.3.5 Presence of the Hox transcription factors during oligodendrogenesis 
Hox genes are TFs that are expressed in almost all embryonic tissues, including 
the nervous system (reviewed in Lumsden and Krumlauf, 1996; Briscoe and Wilkinson, 
2004), determining cell fate and providing positional information for individual cells 
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(Lumsden and Krumlauf, 1996; Trainor and Krumlauf, 2000). Several laboratories 
including ours have recently identified the presence of Hox genes in OLs in the CNS and 
Schwann cells in the PNS (Hao et al., 1999; Arenkiel et al., 2003, 2004; Nicolay et al., 
2004a, b). In the periphery, although early development of Schwann progenitor cells 
appeared normal in the absence of Hoxb1 with respect to specification and population 
number, abnormal projection of the VII nerve occurs at a later stage (Arenkiel et al., 
2003, 2004). In addition, these researchers demonstrated that the majority (over 95%) of 
the myelin sheath that wraps around the VII nerve is derived from rhombomere 4 (r4) 
Hoxb1 expressing neural crest cells (NCCs), implying Hox genes might serve as a marker 
for correct contact and ensheathment between neurons and Schwann cells.  
Our laboratory has demonstrated the presence of Hoxa2 (Hao et al., 1999; 
Nicolay et al., 2004b), Hoxb4 (Nicolay et al., 2004a) and Hoxd1 (Booth et al., 2007) 
during the development of OLs. Although the early development and specification of 
OPCs appear normal in the absence of Hoxa2, primary OPCs isolated from Hoxa2 -/- 
mice displayed a much more advanced phenotype than the wild-type controls 
(unpublished data), which implies a role of Hoxa2 in regulating the proliferation and 
differentiation of OL-lineage cells.  
2.2 Hox genes in neural development and cell proliferation 
Hox genes form a subgroup of the homeobox gene family, which all contain a 
highly conserved homeobox of 183 nucleotides encoding 61 amino acids. The amino-
acid-specified homeodomain is a DNA binding domain that regulates specific DNA-
protein interactions, thereby influencing DNA transcription (reviewed by Akin and 
Nazarali, 2005). In vertebrates, these genes are arranged in four distinct chromosomal 
clusters, whereas their homologs in Drosophila form only one cluster, the HOM-C 
complex (Fig. 5). Interestingly, the chromosomal organization of the genes in the 
Hox/HOM-C cluster usually reflects its A-P expression in the body plan, known as spatial 
colinearity (reviewed by Holland and Garcia-Fernàndez, 1996; Akin and Nazarali, 2005). 
In general, vertebrate Hox genes also display temporal colinearity (Duboule, 1998; Gaunt 
and Strachan, 1996). Thus, the 3´ genes within a chromosomal cluster are activated much 
earlier and expressed more anteriorly than genes located close to the 5´ end, with respect 
to the rostrocaudal axis of the embryo. This colinearity and ordered arrangement of  
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Figure 5. Organization and evolutionary relationships between the Hox clusters (below) 
in vertebrates and HOM-C homeotic complexes (top). Each square represents one Hox or 
Homeotic gene, with its name noted underneath. Only one HOM-C complex is found in 
Drosophila, consisting of two regions: Antennapedia and Bithorax. Unlike Drosophila, 
four paralogous groups exist in vertebrates, presumably derived by duplication of an 
ancestral cluster. In most cases, vertically arranged squares share the same color, which 
indicates they are structurally and/or functionally homologous to each other. At the 
bottom, the anterior-posterior (A-P) order of each Hox member on the chromosome is 
denoted, together with the colinear expression pattern of Hox genes in the CNS of 
vertebrates (Image is taken from Cobourne, 2000 with the permission of author). 
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expression have been observed for Hox genes in a variety of developing tissues, 
particularly in the CNS (Keynes and Krumlauf, 1994; Gaufo et al., 2003; Briscoe and 
Wilkinson, 2004), neural crest and branchial arches (Creuzet et al., 2005), as well as the 
limb buds (Zakany and Duboule, 1999). Homeobox genes are often referred to as “master 
regulatory genes”, setting in motion a complex series of processes necessary for the 
formation of, for example, heads or limbs (Akin and Nazarali, 2005). 
2.2.1 Hox genes are master genes in patterning the neural system 
The vertebrate neural system is a complex and highly compact organization; 
however, it also undergoes regional subdivision during early embryonic development, 
providing a convenient basis for the generation and assembly of diversity. A series of 
transitory segmental elevations, or neuromeres, are formed in the early neural tube. 
Particularly in the hindbrain, morphological repeated units (7 in mouse and 8 in chick), 
also known as rhombomeres (r), have been described (Gaufo et al., 2004). Each r 
generates defined types of neurons according to its A-P position (Fig. 6). Moreover, the 
hindbrain partitioning may underlie spatial establishment of the neural circuitry (Fig. 6) 
and the segmental specification of NCCs, which contribute to the patterning of cranial 
sensory ganglia and the branchial arches (Lumsden et al., 1991; Kontges and Lumsden, 
1996).  
Hox genes are important regulators that control this segmentation and 
specification. In the developing hindbrain (Fig. 6) and the spinal cord (reviewed by 
Lumsden and Krumlauf, 1996; Briscoe and Wilkinson, 2004), Hox genes are expressed in 
overlapping domains along the A-P axis, in a fashion colinear with their positions within 
the cluster on the chromosomes (Fig. 5). The 3' anterior Hox paralogs (1-4) have varying 
rostral expression limits in the hindbrain (Fig. 6), whereas 5' Hox members (5-13) 
generally are detected in the spinal cord, with Hoxa5, Hoxb5 and Hoxc5 having the most 
the most anterior boundary (Carpenter, 2002).  
Accumulating evidence demonstrates that the specific identity of each r and its 
derived cells is regulated by the differential expression of Hox genes (Trainor and 
Krumlauf, 2000). Marshall et al. (1992) report that an alternation in the expression 
profiles of ‘Hox code’ [by retinoic acid (RA)] in mice hindbrain will induce 
transformation of r2/3 into an r4/5 identity. Similarly, disruption of Hoxa1 results in the  
  32
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H
oxa1 
H
oxb1 
H
oxa2 
H
oxb2 
H
oxa3 
H
oxb3 
H
oxd3 
H
oxd4 
H
oxb4 
H
oxa4 
  33
 
 
 
 
 
 
 
 
Figure 6. Patterns of cell organization and expression profiles of Hox genes in chick 
hindbrain. This schematic diagram represents the hindbrain of a chick embryo, which 
during development is subdivided into clearly demarcated units called rhombomeres (r). 
Each r contains reticulospinal neurons (blue or green), the axon trajectories of which are 
related to the rhombomeric divisions. The motor nuclei (in the right side basal plate) are 
IV-trochlear, V-trigeminal, VI-abducens, VII-facial, IX-glossopharyngeal. The bars mark 
the anterior rhombomere boundaries of Hox gene expression, with the name of each gene 
identified at the bottom. The red regions denote higher levels of expression; orange 
regions denote lower levels of expression. Hoxa2 displays the most anterior expression 
domain, up to the boundary of r1/r2.  [Based on Figures 2 and 3 in Lumsden and 
Krumlauf (1996) with the permission of the author] 
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reduction of r4 with an absence of most of r5, a decrease of caudally migrating facial 
MNs, as well as misprojection of some axons (Carpenter et al., 1993; Gavalas et al., 
2003).  In comparison, Hoxb1 has a restricted high level of expression at r4 and loss of 
Hoxb1 leads to a seemingly partial transformation of the r4 to an r2 identity (Studer et al., 
1996; Gavalas et al., 2003). Furthermore, the posterior migratory behavior of the r4-
derived neurons is abnormal in Hoxb1 mutants, adopting a lateral migration similar to 
that of the trigeminal neurons in r2 (Studer et al., 1996). Recently, Arenkiel and co-
workers (2003, 2004) demonstrated that Hoxb1 is also expressed in r4-derived NCCs that 
are fated to generate glia that myelinate the VIIth cranial nerve. Loss of Hoxb1 in the 
peripheral nervous system (PNS) does not alter the early development and specification 
of Schwann progenitor cells, although fewer overall numbers of glial cells are observed 
with the loss or absence of facial branchimotor neurons (FBM) at later stages.      
Hoxa2 is located at the second foci of the 3' end of the paralog group-A 
chromosomal cluster, and exhibits the most anterior boundary of expression in the 
hindbrain of mice and chick, up to the interface of r1/r2 (reviewed in Krumlauf, 1994). 
More recently, data collected from our laboratory uncovered its presence in the 
diencephalon and the forebrain during late embryonic stages and postnatal life in mice 
(Tan et al., 1992; Wolf et al., 2001).  In mice that harbor a null mutation in Hoxa2, the 
r1/2 boundary is missing, the sizes of r2 and r3 are reduced and trigeminal MN axons 
display abnormal projections (Krumlauf, 1994; Gavalas et al., 1997; Barrow et al., 2000).  
Within the hindbrain, diverse groups of interneurons (INs) and MNs are located in 
stereotypic positions in a rhombomere-specific manner. Trigeminal (V) MNs are derived 
from r2/r3 and belong to a class of branchiomotor neurons; facial (VII) MNs are 
generated from r4/r5, and the abducens (VI) MNs are of r5 origin. Hox genes have also 
become prime molecular candidates for providing positional information to neural cells. 
These studies have focused primarily on the specification of MNs (Pattyn et al., 2003; 
reviewed in Briscoe and Wilkinson, 2004; Dasen et al., 2003, 2005). For example, Hoxb1 
is required for the specification of r4-branchial MNs (Studer et al., 1996). Abnormal 
patterns of neural circuitries depicted in other Hox gene mutants indicate that either the 
initial specification of regional MNs is altered, or their differentiation and/or migration 
are changed. Gaufo et al. (2003) demonstrated that the precursors for somatic sensory 
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INs are under the control of Hox genes. According to these researchers, a distinct 
combination of Hox genes in r4 and r5 of the hindbrain are required for the generation of 
precursors for visceral sensory INs.  
Notably, the expression profiles of some Hox genes within the developing spinal 
cord also exhibit a dorsoventral (D-V) pattern along the transverse plane. At E12.5, 
Hoxa4, a5 and a6 genes exhibit a ventral domain of expression in the spinal cord, as do 
Hoxc5 and Hoxd5 (reviewed in Gaunt, 1991). Expression analysis of genes in the B 
cluster reveals dynamic dorsoventral patterns of expression in various coronal sections 
along the A-P axis (Graham et al., 1991). Particularly, Hoxb3 and Hoxb4 have dorsally 
restricted expression, whereas some members that belong to the HoxA and HoxC cluster 
genes exhibit a specific ventral appearance, suggesting a Hox-mediated D-V specification 
of cell populations. This concept is further supported by Hao et al. (1999) whose data 
show dynamic D-V patterns of Hoxa2 in the developing neural tube, which is believed to 
instruct the spatial arrangement of certain groups of neurons.   
2.2.2 Hox genes regulate cell proliferation and differentiation 
Accumulating evidence suggests certain homeobox genes may provide an 
important link between the processes of cell proliferation and tissue development 
(reviewed in Ford, 1998; Levine and Green, 2004; Del Bene and Wittbrodt, 2005; 
Crickmore and Mann, 2006). Much of this evidence comes from cancer studies, where 
many cancers exhibit abnormal levels of Hox genes (reviewed in Ford, 1998; Del Bene 
and Wittbrodt, 2005). For example, ectopic Hox expression obtained by transfection of 
Hox genes into murine and rat cells induces tumorigenicity (Hawley et al., 1997; 
Thorsteinsdottir et al., 1997). Similarly, enforced expression of HOXB4 is associated 
with elevated keratinocyte proliferation, but decreased cell adhesion (Kömüves et al., 
2002), whereas overexpression of the HOXA7 gene was reported to inhibit keratinocyte 
differentiation (La Celle and Polakowska, 2001). As discussed above, during mouse and 
chick CNS development, deletion of a particular Hox gene leads to shortening of the 
hindbrain, and loss or reduction of a certain compartment (Rossel and Capecchi, 1999; 
Barrow et al., 2000). Hence, Hox genes are implicated in cell cycling control, a subset of 
which may be involved in organ size determination, cell differentiation and 
carcinogenesis. 
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Important information also comes from the investigations of Hox/HOX genes in 
hematopoiesis, where Hox genes have been demonstrated to directly modulate cell 
proliferation, differentiation and phenotype. It seems clear that cells representing various 
stages of hematopoietic differentiation display differential overall patterns of Hox/HOX 
gene expression (Magli et al., 1991). More strikingly, genes located at the 3' end of the B 
cluster are expressed primarily in isolated cells that hold positions in the earlier precursor 
hierarchy, whereas the expression of genes close to the 5’ region are progressively 
switched on along the differentiation course (Care et al., 1994; Quaranta et al., 1996). 
Furthermore, over-expression of some Hox/HOX genes, such as HOXB4 and HOXB6, 
generally results in selective expansion of primitive hematopoietic cells (Sauvageau et al., 
1995; Fischbach et al., 2005). In contrast, loss of function studies often lead to reduced 
size of animals and/or organs. Homozygous Hoxa9-/- mice show reduced numbers of 
peripheral blood granulocytes and lymphocytes, smaller spleens and thymuses (Izon et al., 
2006); mice lacking Hoxb4 exhibit significantly reduced cellularity in spleen and bone 
marrow (BM), as well as poor proliferation responses of several BM stem and progenitor 
cells (Bjornsson et al., 2003; Brun et al., 2004). 
All together, the question arises as how Hox genes regulate the proliferation and 
differentiation of the various subtypes of cells. Convincing correlations between Hox 
genes and cell cycling machinery need to be demonstrated. Recent experiments suggest 
that in mice, homeodomain transcription factors Pax6, Chx10, and Otx1 may serve as 
important regulators of cell proliferation by controlling population expansion on several 
levels, from setting the correct rate of proliferation to promoting cell cycle exit (Warren 
et al., 1999; Rhinn et al., 1999; Green et al., 2003). Alternatively, in Drosophila, the 
homeobox gene Ultrabithorax (Ubx) can regulate the size of haltere by restricting the 
transcription as well as the mobility of morphogen Decapentaplegic (Dpp), rather than 
directly impacting the cell cycling components. For clustered Hox genes, Yue and co-
workers (2005) report the up-regulation of cyclin G1 and G2 genes in the uteri of Hoxa10 
mutant mice, indicating these genes act as downstream targets of Hoxa10, which might 
be involved in the negative control of uterine cell proliferation. More remarkably, one 
study clearly demonstrates the expression of Hox genes on the B cluster (except for 
Hoxb1 and Hoxb13) exclusively requires cell proliferation, and the entire locus is 
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progressively activated within one cell cycle in P19 cells (Fisher and Mechali, 2003). 
According to this observation, deletion of a particular HoxB gene can disturb the defined 
pace of the cell cycling machine, thus resulting in reduced cell proliferation and smaller 
organ. However, it is important to point out that Fisher examined the activation of Hox 
genes at the RNA level by RT-PCR. Thus, the actual presence of these TFs at the protein 
level remains to be explored, since post-transcription modification, translation or post-
translation events can also play key roles in controlling the progress of the cell cycling 
machine. In this model, a feedback effect may exist. Hence, at the protein level, a 
particular combination of Hox TFs at a defined time can alter the consequent 
transcription of Hox gene cluster, which then stops the cell proliferation drive, and results 
in cell fate determination or cell differentiation.  
Hox genes have been implicated in stem/progenitor cell expansion, and regulating 
cell proliferation and differentiation (reviewed in Ford, 1998; Levine and Green, 2004; 
Del Bene and Wittbrodt, 2005). However, there are more questions left to be addressed. 
For example, how direct is the regulation of proliferation by these homeobox genes? Is 
there a hierarchy of homeobox genes that converges onto one or two critical Hox genes? 
Or does each homeobox gene contribute independently to ensuring the appropriate rate 
and extent of proliferation? In addition, is this proliferation regulation role of Hox genes 
common for various cell types during embryonic development? Or is it restricted to 
certain tissues, such as the neural system or the blood system? Thus, the discovery of Hox 
genes in OL-lineage cells requires further investigation.  
2.3 Stable OL-lineage cell lines as useful tools to study oligodendrogenesis 
While the in vivo system can provide a more reliable investigative model for 
researchers, the existence of multiple neural cell types and intricate environment can 
often lead to inconclusive results. Pure cultures of OPCs have the advantage of simplicity, 
and have been frequently used for investigating oligodendrogenesis. Primary OPCs can 
be isolated from embryonic mice/rat CNS and cultured in vitro with well established 
methods (Louis et al., 1992; Tang et al., 2000); however, it can be time consuming and 
resource intensive to obtain a homogeneous cell population in adequate quantity to 
conduct genetic manipulations. A number of immortalized CNS glial cell lines have been 
established, by transfection with simian virus 40 (SV40) large T mutant oncogene (Verity 
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et al., 1993; Bernard et al., 1994; Matsushita et al., 2005) or t-neu oncogene (Jung et al., 
1995), from spontaneously transformed cells isolated from Wistar rat (Richter-Landsberg 
and Heinrich, 1996) or from cultures isolated from jimpy mouse brain (Feutz et al., 1995, 
2001) (Table I). Although these attempts have succeeded in establishing permanent cell 
lines expressing OL-lineage markers, they either failed to fully retain characteristics of 
primary O-2A cells (Richter-Landsberg and Heinrich, 1996), or became heterogeneous 
after long periods of cultures (Barnett et al., 1993), or failed to differentiate into mature 
OLs in vivo (Barnett et al., 1993).   
CG4 cells, a permanent cell line derived from primary cultures of O-2A 
progenitor cells isolated from rat cerebral cortex, is to date one of the two non-
immortalized cell lines (Louis et al., 1992; Lagarde et al., 2007). As reported by Louis et 
al. (1992), during the preparation of primary O-2A cells, a group of O-2A cells (named 
CG4) escaped the usual fate and kept on proliferating for more than a year in vitro in 
defined medium, and thus was developed as a non-transformed O-2A cell line. The same 
research group also demonstrated that the phenotype, antigenic characteristics and 
bipotential differentiation of the CG4 cell line closely resemble those of cerebral O-2A 
cells (Louis et al., 1992). In addition, during maturation along the OL path, CG4 cells 
displayed morphological changes and corresponding cell markers that are consistent with 
that of primary OPCs, both in vitro and in vivo (Louis et al., 1992; Franklin et al., 1995). 
Since CG4 cells bear a normal genotype as primary O-2A cells, they have been 
frequently employed in in vivo transplantation studies to explore the potential therapeutic 
use of these cells in myelin-related disorders (Tontsch et al., 1994; Franklin et al., 1995, 
1996; Tourbah et al., 1997; O’leary and Blakemore, 1997). The above mentioned features 
have made the CG4 cell line a good cell culture model to study OL development. Hence, 
the CG4 cells have been widely employed for studying gene function, cell myelination 
and signal transduction in oligodendrogenesis (reviewed in Franklin and Blakemore, 
1997; Espinosa de los Monteros et al., 1997; Fatatis and Miller, 1997; Miskimins et al., 
2002; Magy et al., 2003). In the present thesis, the CG4 cell line was used to establish 
stable cell lines where Hoxa2 gene expression can be conditionally up- or down-regulated.  
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Table I.  Permanent OL-lineage cell lines 
 
Type of cell line Name Reference 
Immortalized N20.1 Verity et al., 1993 
Immortalized CR15 and CM8 Bernard et al., 1994 
Immortalized Oli-egfr-neu Jung et al., 1995 
Immortalized Oli-neu Jung et al., 1995 
Immortalized OLN93 
Richter-Landsberg and Heinrich, 
1996 
Immortalized OLP6 Matsushita et al., 2005 
Immortalized 158N Feutz et al., 1995, 2001 
Immortalized 158JP Feutz et al., 1995 
non-immortalized CG4 Louis et al., 1992 
non-immortalized O1 Lagarde et al., 206 
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III MATERIALS AND METHODS  
3.1 Cell cultures 
CG4 cells, an O-2A precursor cell line derived from new-born rat cortical cultures 
described previously (Louis et al., 1992), were used in this study. In all experiments, 
CG4 cells were cultured and maintained on Poly-D-Lysine (P-D-L) (Sigma) coated tissue 
culture dishes in growth medium (GM), composed of DMEM (Sigma), 50 μg/mL 
transferrin (Sigma), 5 μg/mL insulin (Sigma), 10 pg/mL biotin, 50 ng/mL selenium, and 
30% B104 conditioned medium (B104CM). 
For the production of B104CM, B104 neuroblastoma cells were plated at 5 x105 
cells per 100 mm2 dish and cultured in DMEM:F12 (1:1) with 10% of FBS until they 
reached 90% of confluence, after which the medium was changed to a defined medium 
comprised of DMEM (Dulbecco’s Modified Eagle Medium) and 1% TPPS (1 mg of 
holo-transferrin bovine; 1.0 mM of putrescine; 2 mM of progesterone and 30 μM of 
sodium selenite). After 3-day incubation, the serum-free defined medium was collected, 
filtered and stored at -80 °C for storage.  
To induce in vitro differentiation of the progenitor cells, growth medium was 
switched to differentiation medium (DM), which consisted of DMEM, 0.4% FBS, 50 
μg/mL of transferrin, 2.5 μg/mL of insulin, 10 pg/mL of biotin and 50 ng/mL of 
selenium.  
3.2 Genetic basis for the Tet-off gene expression system 
The tetracyclin-based inducible systems (Tet-on/Tet-off) make use of the E.coli 
tetracyclin (Tet) resistance operon for regulating gene expression in a large collection of 
cell and animal models. The Tet-off expression system consists of two vectors (Figure 7), 
the first vector encodes a tetracycline-controlled transactivator protein (tTA), which is 
composed of the Tet repressor DNA binding domain (TetR) from the Tc resistance 
operon (Appendix I). The second vector contains multiple cloning sites (MCS) for 
inserting the target gene, which is under transcriptional control of a tetracycline-
responsive promoter element (TRE) (Appendix II). The TRE is made up of Tet operator 
(tetO) sequence concatemers fused to a minimal promoter. In case of Tet-off, the 
presence of Tet or doxycycline (Dox) prevents tTA from binding to the TRE site and 
inhibits the transcription of target gene. Withdrawing Dox allows tTA binding to the TRE 
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site and activates the downstream transcription.  
Figure 7 illustrates the processes to establish the two stable cell lines, where 
Hoxa2 can be either up- or down-regulated. The CG4 cells were firstly transfected with 
the pTet-off vector, which contains the tTA encoding region as well as a neomycin 
resistance allele, followed by G418 selection to select stable cell clones. Surviving clones 
were screened by transient transfections with control vector pTRE2hyg2-Myc-Luc for 
clones with low background and high Dox-dependent induction. A second transfection 
introduced the second vector which harbours sense-Hoxa2 or anti-sense-Hoxa2, as well 
as the hygromycin resistance gene. Cells survived the hygromycin selection were then 
subjected to RT-PCR and western blot analysis. 
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Figure 7. Schematic diagram depicts the procedures for developing the tetracycline (Tet) 
controlled gene expression system in CG4 cells. Initially the pTet-off vector (linearized 
with ScaI), which encodes the tetracycline-controlled transactivator (tTA), is introduced 
into the CG4 cells. Selection of stable clones that consistently express tTA was 
performed by G418 (300 µg/mL) screening. After selection, a control vector, 
pTRE2hyg2-Myc-Luc (Clontech), was introduced transiently into the G418-resistant 
clones to determine their inducibility by measuring the luciferase activity. Clones that 
gave the highest luciferase expression (Fig.12) were selected for subsequent experiments. 
A second stable transfection with the recombinant vectors, harboring the Hoxa2 gene 
(sense or anti-sense), was carried out by using electroporation. The hygromycin resistant 
property of the pTRE2hyg2-Myc was utilized in the selection of double stable cell clones, 
which would either up-regulate or down-regulate the expression of Hoxa2.  
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3.3 Plasmids construction 
The pTet-off vector (Appendix I) was a gift from Dr. Peter Dickie (University of 
Alberta). The pTRE2hyg2-Myc (Appendix II) and pTRE2hyg2-Myc-Luc vectors were 
purchased from BD Biosciences (Clontech, Mountain View, CA). Sense cDNA of Hoxa2 
was PCR amplified using forward primer 5’-CATCGATAGAAGGCCAT GAATTACG-
3' and reverse primer 5'-TCGTCGACTTAGTAATTCAGATGC-3' from the pRSV-
Hoxa2 vector. Antisense cDNA of Hoxa2 gene was amplified by PCR using forward 
primer 5'-GCTGTAATATCGATGTAATTCAGATGCTGTAGG-3' and reverse primer 
5'-AGGAGGTCGACATGAATTACGAATTTGAGC-3' (restriction enzyme sites are 
underlined). The PCR products of sense Hoxa2 cDNA and antisense Hoxa2 cDNA were, 
respectively, double digested with SalI and ClaI, and subsequently cloned into the SalI / 
ClaI site of the pTRE2hyg2-Myc vector. All constructs were confirmed by sequencing 
(Appendix VIII shows the alignment of sequencing data of pTRE2hyg2-Myc-
SenseHoxa2 with Hoxa2 cDNA). The pTRE2hyg2-Myc-Luc vector (Clontech, Mountain 
View, CA) contains the Luciferase reporter and was used as a control for determining the 
expression profile of the Tet system in CG4 cells.  
3.4 Titrating G418, hygromycin and doxycycline 
Prior to transfection, kill curves were created for the antibiotics G418, 
hygromycin and doxycycline (Dox) to determine the optimal concentration for selection 
with CG4 wild-type cells. Wild-type CG4 cells were seeded at 2 x 105 per 100 mm tissue 
culture, and grown in 10 mL of GM with varying amounts of G418 (0, 100, 300, 500, 700 
μg/mL) or hygromycin (0, 50, 100, 200, 400, 600 μg/mL). For Dox, this selection agent 
was tested at concentrations of 0, 1, 2, 4, 6 μg/mL. Selective medium was replaced every 
two days with fresh medium containing the same amount of antibiotic. According to 
Clontech protocol (PT3001-1), the lowest concentration that begins to cause massive cell 
destruction at day 5 and kills all the cells within two weeks was used for selecting stable 
transformants. For CG4 cells, 300 μg/mL of G418, 200 μg/mL of hygromycin and 2 
μg/mL of Dox proved to be optimal. In addition, for G418, after stable transformants 
were selected and confirmed, a lower concentration (100 μg/mL) of this antibiotic was 
used to maintain a selection threshold (Clontech PT3001-1). 
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3.5 Transfections and engineering of double stable cell lines  
Plasmids used for transfection were purified by using the EndoFree Plasmid Maxi 
Kit (Qiagen, Mississauga, Ontario). After DNA purification, 30 μg of pTet-off vector was 
linearized with HindIII, followed by phenol extraction and ethanol precipitation. 
Linearized pTet-off plasmid (10 μg) was added to 30 µL of 2.5M CaCl2 and made up to a 
total volume of 150 µL in water. The DNA-Ca3(PO4)2 precipitate was prepared by 
adding the above mixture dropwise to an equal volume of 2XHBS (280 mM NaCL, 10 
mM KCl, 1.5 mM Na2HPO4, 12 mM glucose and 5 mM HEPES, pH7.0-7.1) while 
vortexing. This mixture was allowed to sit in the hood for 15 min before being slowly 
added to a 60 mm dish of 80% confluent CG4 cells, which was plated 24 h before 
transfection. The cells were incubated with the DNA precipitate in a humidified incubator 
in 5% CO2 at 37 °C. After 12 h, the cells were rinsed with Puck's (200mM NaCl, 5mM 
KCl, 4mM NaHCO3, 5.5mM glucose) and incubated with fresh GM for 48 h before G418 
selection. Stable CG4-tTA clones were selected in the presence of 300 μg/mL of G418 
(Sigma, St. Louis, MO) in 100 mm2 dishes until 11 cell clones were obtained. 
The CG4-tTA clones isolated were examined for their ability to induce gene 
expression by transient introduction of the control vector pTRE2hyg2-Myc-Luc into 
these cells using the calcium phosphate precipitation method. Luciferase activities were 
measured and a clone (clone 2) that gave the highest reading was subsequently used in 
the follow up experiments. 
Electroporation was adopted in the following transfections with recombinant 
plasmids pTRE2hyg2-Myc-SHoxa2 and pTRE2hyg2-Myc-ASHoxa2, and was carried out 
using Gene Pulser and a 0.4 cm electroporation cuvette (Bio-Rad Laboratories, Hercules, 
CA). CG4-tTA cells were plated onto 1002 mm dishes at 8 x 105 cells per dish two days 
before transfection. Fresh medium was supplied to the culture 5 h before the 
electroporation. The cells were then harvested and collected at a concentration of 5 x 106 
cells per mL in electroporation medium (EM), a 1:1 mixture of HBS and GM (with twice 
the concentration of insulin described above). Twenty micrograms of DNA was diluted in 
20 µL sterile water and added to a 780 µL cell suspension. Electroporations were 
performed at room temperature with a charge of 0.34 KV at a capacitance of 250 µF. 
After electroporation, the cells were allowed to sit undisturbed in the hood for 10 min, 
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and then transferred onto culture dishes in recovery medium (RM), comprised of DMEM 
5%, insulin 5 μg/mL, pyruvate 2 mM and antibiotic/antimiotic 100 μg/mL. The medium 
was changed to the regular GM after 2 h incubation in RM. Hygromycin B (Sigma, St. 
Louis, MO) (200 μg/mL), G418 (100 μg/mL) and Dox (2 μg/mL) were added into the 
GM two days later for selection, and fresh GM with these drugs was fed every other day. 
Double-transfectant clones appeared after 3~4 weeks screening with 200 μg/mL of 
hygromycin B and 100 μg/mL of G418. Hygromycin resistant clones that were selected 
for the following proliferation and differentiation assay were named CG4-SHoxa2 (sense 
Hoxa2 up-regulation) and CG4-ASHoxa2 (anti-sense Hoxa2, down-regulation) cells, 
respectively. These clones were maintained in medium containing 100 μg/mL of G418 
and 200 μg/mL of hygromycin B and kept under liquid nitrogen for long-term storage. 
3.6 Luciferase assays 
CG4-tTA cells were seeded at 2 x 105 on 35 mm2 P-D-L coated dishes the day 
before transfection. Transfections were performed as described above. After growth for 
48 h in the appropriate medium, cells were then washed twice with Puck's prior to 
harvesting for Luciferase assay using the Dual-Luciferase® Reporter assay kit (Promega 
Corp., Madison, WI). In brief, cells were subjected to 500 µL Passive Lysis Buffer 
(PLB), where 20 µL of the cell lysate were added to 100 µL of Luciferase assay reagent 
AR II and luminescence was measured. Luciferase activities were calculated as relative 
light units (rlu) /mg of total cellular protein. 
3.7 Western blot analysis 
For detection of the expression level of Hoxa2 protein, and to confirm the 
establishment of the double stable cell lines that contain the Tet-off system, CG4 cells 
and genetically modified CG4 cells were seeded at 3 x 105cells per well in a 6-well dish, 
and cultured in the presence or absence of 2 μg/mL of Dox. Following two days of 
growth in GM or DM, cells were harvested and lysed with RIPA buffer (150 mM NaCl, 
0.5% SDS, 1% Triton-100, 0.1% deoxycholate, 10 mM Tris-HCl [pH 7.2], 5 mM 
EDTA). Protein quantification was completed using a Bio-Rad DC Protein Assay kit 
(Bio-Rad, Richmond, CA). Equivalent amounts of protein for each sample were 
electrophoresed on a 12% polyacrylamide/0.1% SDS gel and subsequently transferred to 
a PolyScreen® PDVF transfer membrane (PerkinElmer, Boston, MA). Transfer buffer 
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was composed of 10% methanol, 25 mM Tris-HCl [pH 7.2], and 199 mM glycine. The 
transfer was performed for 1.5 h at 30V/200 mAmp at room temperature (RT). After 
being blocked with 3% skim milk (SM) in phosphate-buffered saline (PBS) at 4°C 
overnight, the membrane was immunoblotted with a polyclonal rabbit antibody specific 
to Hoxa2 (Hao et al., 1999) at a dilution of 1:3000 in SM-PBS for 1 h at RT. Repeated 
washings (3 washes of 20 min each) were carried out in PBS with 0.08% Tween-20 
(PBS-T), before the membrane was incubated with the secondary antibody, goat anti-
rabbit IgG horseradish peroxidase conjugate (HRP) in SM-PBS at a 1:3000 dilution for 1 
h at RT. After extensive washings and treatment with a chemiluminescence reagent 
(DuPont NEN®, Boston, MA), Hoxa2 protein expression was visualized on an X-ray 
film (Kodak Industrie, Cedex, France). The same membrane was blotted again with a 
monoclonal antibody specific to β-actin as an internal control (JLA20, 1:3000; 
Developmental Studies Hybridoma Bank, Iowa) for 1 h at RT, followed by a secondary 
anti-mouse IgM antibody (1:3000) for 1 h at RT.  
3.8 Immunocytochemistry 
For immunostaining, cells were plated onto P-D-L coated 15 mm2 coverslips and 
grown as described above. The following primary antibodies were utilized: anti-Hoxa2 
(1:800, Hao et al., 1999), A2B5 (1:100, ATCC), O4 (1:50, hybridoma; Sommer and 
Schachner, 1981), and anti-galactocerebroside (GalC) (1:100, hybridoma; Ranscht et al., 
1982). A2B5, O4, GalC were used to mark cells at different stages of OL development 
(Fig.1). Double labelling of Hoxa2 with A2B5, O4, or GalC was conducted using a 
procedure described previously (Doucette and Devon, 1994) with the following 
modifications: live cells were incubated for 45 min at 37 ˚C in A2B5, O4, or anti-GalC 
monoclonal antibodies diluted in PBS; the blocking and permeabilization steps were 
combined with a 30-min incubation in 3% skim milk powder solution containing 0.1% 
Triton X (3% SM/0.1% TX); the cells were incubated for 4 h at RT in anti-Hoxa2 diluted 
in 1% SM/0.03% TX. The secondary antibodies utilized include anti-mouse IgM 
fluorescein isothiocyanate (FITC) (1:100, A2B5/O4, Sigma), donkey anti-mouse IgG 
FITC (1:50, GalC, Bio/CAN), and goat anti-rabbit IgG CY3 (1:200, Hoxa2/GFAP, 
Bio/CAN). Between incubations, cultures were washed twice for 5 min in PBS. 
For the differentiation assay, cells were double labelled with O4 and anti-GalC 
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antibodies. Cells were fixed with 4% paraformaldehyde first, followed by incubation with 
primary antibodies of O4 and GalC at 37 ˚C for 45 min. After blocking with skim milk, 
coverslips were incubated with secondary antibodies which contained anti-mouse IgM 
Alexa Fluor 594 (1:500, O4, Sigma) for O4, and anti-mouse mouse IgG FITC for 
detection of GalC. 
In all the stainings, nuclei were visualized by using Hoechst dye (Sigma, ON). 
The percentage of a particular population of OLs, positive for one of the following 
markers A2B5 (A2B5+ve), O4 (O4+ve), GalC (GalC+ve), and BrdU (BrdU+ve) markers 
was calculated from three independent experiments, with more than 500 cells counted in 
total for each coverslip.  
3.9 Measure proliferation rate of cells by BrdU incorporation assay 
CG4 cells were sub-cultured from the same passage and seeded onto 15mm2 
coverslips at 1x105 cells per well (2 coverslips per each well) in the 6-well dishes and 
maintained in GM, either supplemented with Dox or No Dox, two days before addition of 
BrdU. To induce cell differentiation, GM was changed to DM on the next day, and cells 
were subsequently cultured in DM for 2 days before the BrdU assay. BrdU was supplied 
for the last 12 h of incubation at a final concentration of 1 µM. Detection of BrdU was 
performed as follows: cells were fixed in ice-cold 4% paraformaldehyde for 15 min, 
followed by a 30 min incubation in 2 N HCl and a 20 min incubation in 3% skim 
milk/0.1%TritonX-100; cells were further incubated in anti-BrdU antibody (1:200, 
Sigma) in PBS for 1 h at RT. After several washes in PBS and incubation in secondary 
antibody (donkey anti-mouse IgG FITC [1:50] in PBS) for 30 min at RT, cells were 
counter stained with Hoechst dye.  
To examine the developmental stage of BrdU+ve cells, either in GM or DM, 
double labelling of BrdU with either A2B5 or O4 antibodies was conducted. Cells were 
fixed first following a 12h-incubation with BrdU, and then subjected to the primary 
antibody (A2B5 or O4) for 45 min at 37 ˚C. After permeabilization, cell surface markers 
were detected using anti-mouse Alexa Fluor 594. A further fixation was performed 
before BrdU staining was carried out as described above.  
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3.10 Quantitative analysis of cell differentiation 
For the quantitative differentiation analysis, 4x105 cells of CG4 or CG4-SHoxa2 
were seeded on each well of the 6-well dish (35 mm2) (Fig. 7). Cells were further 
maintained in GM for overnight (16 h), since directly changing into DM resulted in poor 
attachment and a substantial amount of cell death. GM was then replaced with freshly 
made DM after thoroughly washing with Puck’s saline. As illustrated in Figure 7, well 1 
and 4 were incubated in DM for 2 days, the middle two wells (2 and 5) were maintained 
in DM for 3 days, whereas the last two (3 and 6) were kept for 4 days. Cells in places 1, 2 
and 3 were continuously cultured in the presence of Dox (2µg/mL), while the bottom 
three wells (4, 5 and 6) were not subjected to Dox treatment. Each well contained two 
coverslips, one of which was utilized for double staining with anti-A2B5 and anti-GFAP, 
and the other used for detection of O4 and GalC.  
3.11 Microscopy 
We observed live cell cultures using an Olympus CKX41 light microscope, with 
objective lens magnification of either x10 or x40; pictures were taken by Nikon 
CoolPix4500 camera. Fluorescent images were examined with an Olympus BX40 
microscope equipped with appropriate filter sets, and pictures were analyzed with the aid 
of Image-Pro Imaging software (Media Cybernetics).  
3.12 RNA isolation and semiquantitative reverse transcription polymerase chain 
reaction (RT-PCR) 
For detection of the mRNA of PDGFαR, CGT (Oligodendrocyte-specific 
ceramide galactosyltransferase), MBP and Hoxa2, CG4 and CG4-SHoxa2 cells were 
plated in 6-well dishes at 3x105 cells per well and cultured in GM overnight either in the 
presence or absence of Dox. To induce cell differentiation, the medium was changed to 
DM the next day and cells then were incubated for either 2 or for 3 days. Cells were 
rinsed twice with Puck’s before total RNA isolation, which was performed by using the 
RNeasy Protect Mini Kit (Qiagen, Mississauga, ON). The concentration of RNA was 
determined by OD (optimal density) measurements of aliquots at a wavelength of 260 
nm. For detailed information on primers and PCR products please refer to Table II.  
Subsequently, 200 ng of total RNA for each sample were reverse transcribed into 
cDNAs with the enzyme Superscript® reverse transcriptase (Invitrogen) using a random  
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Figure 8. Schematic illustration of the set up of the differentiation assay in culture dishes 
treated with doxycycline (Dox) or untreated (No Dox) at different time points (day 2, 3 
and 4). Cells were sub-cultured from the same passage, and seeded onto a 35 mm2 
surface (one well) of the 6 multi-well plate (4x105 cells per well). Cells were allowed to 
recover in growth medium (GM) for 16 h after the split, with the upper three wells (1, 2 
and 3, red color) supplemented with Dox, whereas cells in the bottom three wells did not 
receive Dox (4, 5 and 6, red color). GM was replaced with differentiation medium (DM) 
after 16 h, and the wells 1, 2, 3 remained treated with Dox. Each well contained two 
coverslips, with one coverslip subjected to A2B5/GFAP double immunostaining and the 
other one for double labelling of O4/GalC. Wells 1 and 4 were subjected to 
immunostaining after two days incubation in DM. Coverslips in wells 2 and 5 were used 
for the 3 DM study, and coverslips in wells 3 and 6 were subjected for the 4 DM study.  
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hexamer oligonucleotide primer in a standard RT-PCR reaction according to the 
manufacturer. The synthesized cDNAs were then used as templates for PCR  
amplification with primers specific for the genes of interest (Table II). PCR was carried 
out in a reaction of 50 µL containing 1 x PCR buffer (20 mM Tris.HCl [pH8.3], 25 mM 
KCl, 1.5 MgCl2, 0.1% Tween 20), 200 µM concentrations of each of four 
deoxynucleotide triphosphates, 20 pmol of primers, 5 U of Taq DNA polymerase, and 2 
μL of the reverse transcribed template. PCR was performed in a PTC-100TM thermal 
cycler (MJ Research, MA). The PCR program started with an initial denaturation at 95 
°C for 1 min, followed by 40 cycles with each cycle consisting of 94 °C for 45 s, 53 °C 
for 1 min, and 72 °C for 1 min and ended with a final extension of 4 min at 72 °C. PCR 
products were analyzed on 1.5% agarose gel following electrophoresis and visualized by 
staining with ethidium bromide. All pictures were photographed and analyses were 
conducted with an AlphaImagerTM Gel Imaging System. 
 
TABLE II.  Sequences of Primers and PCR Product Sizes Used in the RT-PCR 
 
   * Harvard Center for Neurodegeneration & Repair, Advanced Tissue Resource Center. 
 
 
 
 
 Gene      Primer          Sequence                                        Size (bp)        Reference 
PDGFαR    Forward 
                   Reverse      
5'-GCCAGGAGACGAGGTATCAA-3'   426          (Hu et al., 2004) 
5'-TGTTCCCAATGCCAAGGTC-3' 
CGT           Forward     
                   Reverse      
5'-GGAGATTGCCTCAGAAAGT-3'      428             (Hu et al., 2004) 
5'-GTCGTGGCGAAGAATGTAG-3'       
MBP           Forward     
                   Reverse 
5'-CTATAAATCGGCTCACAAGG-3'    176         ATRC Reagent Bank* 
5'-AGGCGGTTATATTAAGAAGC-3' 
β-Actin      Forward 
                  Reverse 
5'-ATTGTAACCAACTGGGACG-3'      553             (Hu et al., 2004) 
5'-TTGCCGATAGTGATGACCT-3' 
Hoxa2        Forward  
                   Reverse 
5'-GGGAAGGGTACACTTTTCAGC-3'  151            UniSTS:143365 
5'-TTAGGAACAGTGGGTGACTGG-3' 
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3.13 Statistical analysis 
For immunostaining experiments, the median was calculated for data from each 
cell group in each round of the study; data was further analyzed by ranks using a Kruskal-
Wallis two-way nonparametric ANOVA (GraphPad Prism 4) followed by Dunn’s 
multiple comparison test. For analyzing RT-PCR data of PDGFαR, CGT and MBP, the 
optical density ratio between each target band and internal control band (β-actin) was 
obtained using the AlphaImagerTM Gel Imaging Software. The ratios were subsequently 
analyzed by one-way ANOVA followed by Tukey's multiple comparison post hoc tests in 
GraphPad Prism if p value is significant. A p value of less than 0.05 was considered to be 
significant. 
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IV RESULTS 
4.1 Phenotype of CG4 cells in culture during the course of differentiation 
Previous work from our laboratory has identified for the first time the expression 
of Hoxa2, Hoxb4 and Hoxd1 genes in vivo throughout OL development (Hao et al, 
1999; Nicolay et al., 2004a, b; Booth et al., 2007). In particular, Hoxa2 expression is 
indicated to be down regulated at late stages during OL maturation. Although the 
specification and early development of OPCs appear to proceed normally in the Hoxa2-
/- mice, data from our laboratory (unpublished) indicate that OPCs isolated from the 
mutant mice display more processes and are less efficient at myelinating axons in 
OL/neuron co-cultures. Since Hoxa2 null mice die within the first 24h of birth and 
obtaining sufficiently pure primary cultures of OLs is difficult, we have been unable to 
investigate the potential role of Hoxa2 during the late developmental stages of OL and to 
determine how OLs and neurons interact with each other in the Hoxa2 null mice. The 
CG4 cells provide a suitable model to establish a tetracycline (Tet) regulated inducible 
Hoxa2 expression system.  
CG4 cells was established and regularly maintained in GM based on published 
protocols (Louis et al., 1992), described in the methods section (3.1). First, I carefully 
examined the morphological characteristics of CG4 cells, an O-2A precursor cell line, 
along their developmental pathway. At the progenitor stage, undifferentiated CG4 cells 
display a typical bipolar or tripolar phenotype with long unbranched processes (Fig. 9A), 
and produce progenitor stage cell surface markers A2B5 (Fig. 10A). To preserve this 
characteristic bipolar morphology, wild-type CG4 cells were maintained in GM and sub-
cultured before reaching 80% of confluence according to previous studies (Louis et al., 
1992; Raff et al., 1998). To initiate the OL-like differentiation of CG4 cells, the medium 
was changed from growth medium (GM) to differentiation medium (DM). After 2 days 
of incubation in DM, the developing network of membrane processes became visible 
and most cells acquired a multipolar phenotype, with 4-6 branched long processes and 
some thin, small unbranched processes (Fig. 9B). When the cultivation in DM was 
prolonged to 3 days, the cells enlarged their network of membrane processes and 
assumed an even more complex structure of membrane extensions (Fig. 9C). 
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Figure 9. Morphological characteristics of the CG4 cells at progenitor stage (A), late-
progenitor stage (B) and pre-myelinating stage (C). A. CG4 cells were grown in defined 
growth medium (GM). The majority of the cells (>99.9%) displayed bipolar or tripolar 
phenotype with long and smooth process extending from the nuclei. The cells maintained 
in differentiation medium (DM) for 2 days (B) or 3 days (C) acquired a much more 
advanced phenotype. Scale bar indicates 25 μm. 
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Unfortunately, cells detached from the culture plates and/or the coverslips when 
incubated in DM for longer than 3 days, impeding the study of OL cells at the later 
myelin basic protein (MBP) stage of development. In addition, during the differentiation 
of CG4 cells in DM, cells were examined for glial fibrillary acidic protein (GFAP) 
staining, since CG4 cells are also able to give rise to type 2 astrocytes (Louis et al., 
1992). No GFAP positive cells were observed during the 3 day differentiation assay 
throughout the study (data not shown).  
4.2 Hoxa2 is co-expressed with A2B5, O4 and GalC in CG4 cells    
The expression of Hoxa2 protein was investigated in CG4 cells by 
immunocytochemistry (Fig. 10) and western blot analysis (Fig. 13). In agreement with a 
previous in vivo investigation (Nicolay et al., 2004), the presence of Hoxa2 was detected 
in the nuclei of CG4 cells expressing OL-lineage specific cell surface antigens, as 
revealed by the detection of A2B5 (Fig. 10A), O4 (Fig. 10D) and GalC (Fig. 10G) along 
their differentiation course. The nuclei were visualized using nuclear fluorescent 
Hoechst counter stains (Fig. 10 C, F, and I).  Co-expression of Hoxa2 with OL-lineage 
markers A2B5, O4 and GalC was observed in over 98% of the total cell culture 
population.  
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Figure 10. Double immunostaining of Hoxa2 (B, E, H) with A2B5 (A), O4 (D), and 
GalC (G), respectively, in CG4 cells cultured in DM for 3 days. Cell nuclei were 
visualized using nuclear fluorescent Hoechst counter stain (C, F, I) of the same field. 
Scale bar indicates 10 μm.  
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4.3 Construction of pTRE2hyg2-Myc-SHoxa2 and pTRE2hyg2-Myc-ASHoxa2 
vectors 
 Control over the timing and level of gene expression is an important parameter to 
consider in the analysis of gene function or application in gene therapy. Several inducible 
gene expression systems have been developed for this purpose (reviewed in Zhu et al., 
2002), and we adopted the Tet controlled system, or ‘Tet-off’, which can be successfully 
applied in CG4 cells with no toxic effects on endogenous cellular process (Magy et al., 
2003).  
The recombinant vectors, named pTRE2hyg2-Myc-SHoxa2 (containing sense 
Hoxa2 in frame) and pTRE2hyg2-Myc-ASHoxa2 (containing anti-sense Hoxa2 in 
frame), were confirmed by PCR, restriction enzyme digestion (Fig. 11) and DNA 
sequencing (Appendix IV).     
4.4 Establishment of the CG4-SHoxa2 and CG4-ASHoxa2 cell lines 
Two sequential stable transfections were required to engineer the Tet (Dox) 
modulated Hoxa2 expression system in the CG4 cells, as shown in Figure 7 as a 
schematic representation (Materials and Methods 3.2). The vector, pTet-off expressing 
the tetracycline transcriptional activator (tTA), was first introduced into the CG4 cells by 
DNA-calcium-phosphate precipitation. Stable cell clones carrying the pTet-off plasmid 
were selected by screening with 300 µg/mL of active G418, a dosage determined from 
kill curve tests on wild-type CG4 cells (see Materials and Methods 3.4).  
To ensure the Tet-off system was able to regulate gene expression in CG4 cells, 
and to select cells that exhibit the highest inducibility, eleven G418-resistant clones were 
examined for their functional inducibility by transient transfection with the pTRE2hyg2-
Myc-Luc vector. This control vector contains an additional 1653 bp fragment encoding 
firefly luciferase inserted into the MCS, and was used as a reporter of induction 
efficiency. Among the 11 clones, clone 2 (CG4-tTA cells) showed the highest fold 
induction as indicated by measuring the luciferase activity in the absence of Dox 
(Fig.12), and therefore was selected for subsequent experiments. The vectors containing 
either the sense Hoxa2 or anti-sense Hoxa2 gene were transfected into the CG4-tTA cells, 
respectively, by electroporation; double-transfectant clones were selected after exposure 
to 200 µg/ml of hygromycin.   
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Figure 11. Confirmation of the recombinant vectors (pTRE2hyg2-Myc-SHoxa2 and 
pTRE2hyg2-Myc-ASHoxa2) by PCR amplification (Lane 2 & 3) and enzyme (ClaI / Sa 
I) digestion (Lane 4 & 5). Lane 2 and 3 are PCR amplification of Hoxa2 (either sense- or 
antisense-) insert using constructed vectors pTRE2hyg2-Myc-SHoxa2 and pTRE2hyg2-
Myc-ASHoxa2 as template, respectively. Both vectors were subjected to ClaI / SalI 
double digestion. In all cases a fragment of 1119 bp was obtained, which represents either 
sense Hoxa2 (Lane 4) or anti-sense Hoxa2 (Lane 5). The larger bands in lane 4 and lane 5 
are linearized vector pTRE2hyg2-Myc after digestion. Lane 1 is 1kb DNA ladder 
(Invitrogen). 
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Figure 12. Measurement of the luciferase activities of the eleven G418-resistant cell 
clones as indication of induction efficiency of individual clone. Cells were grown in GM 
in the absence of Dox and G418, and were transiently transfected with the luciferase 
control vector pTRE2hyg2-Myc-Luc. The first bar indicates background luciferase 
activity in wild-type CG4 cells. The numerical number underneath each bar stands for 
each CG4-tTA clone. Luciferase activity was expressed as relative light unit [Rlu(s)]. 
Data represents a mean of two repeated experiments.   
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4.5 Regulation of the expression of Hoxa2 in CG4-SHoxa2 and CG4-ASHoxa2  
The “Tet-off” system is a transcription activation system with a pTet-off regulator 
plasmid that is controlled by tetracycline (Tet) or its analogue doxycycline (Dox). In this 
binary transgenic system, expression of Hoxa2 or anti-sense Hoxa2 by CG4 cells is 
repressed when Tet or Dox is added to the culture medium and is induced upon 
withdrawal of Tet or Dox.  
The expression of Hoxa2 was detected in cells cultured in GM either in the 
presence or absence of Dox (2 µg/ml) by western blot analysis (Fig. 13B) after 
transfection with plasmid pTRE2hyg2-Myc-SHoxa2 or pTRE2hyg2-Myc-ASHoxa2 and 
hygromycin selection. The transfected cells were maintained in GM supplemented with 
G418 (100 µg/mL), hygromycin (200 µg/mL) and Dox (2 µg/mL) for over 4 weeks 
(Material and Methods, 3.3 and 3.4). In total, ten double stable clones containing both 
pTet-off and pTRE2hyg2-Myc-SHoxa2 plasmids survived and were then transferred to 
new culture area using cloning cylinders. These ten double stable clones were referred to 
as clones I through X. Individual RNA samples, isolated from each clone cultured in GM 
without Dox supplement, were prepared for RT-PCR to determine whether the Hoxa2 
gene was up- or down-regulated at the RNA level (Fig. 13A) (PCR primers described in 
section 3. 11). Clone X exhibited the highest level of mRNA of Hoxa2, and was named 
the CG4-SHoxa2 cell line. Descendants of clone X were subjected to western blot 
analysis to examine the expression level of Hoxa2 protein (Fig. 13B). In comparison, 
only four antisense-Hoxa2 containing double stable clones (clone i, ii, iii, iv) were 
obtained after transfection and antibiotic screening, due to poor attachment and low 
viability of the antisense-Hoxa2 harbouring cells. Antisense-clone-i, namely CG4-
ASHoxa2 was used for western blot analysis (Fig. 13B), because this cell clone exhibited 
a relatively faster proliferation rate and higher viability after subculture.  
Wild-type CG4 cells treated with or without Dox were used as the controls, and as 
shown in Figure 13 the presence of Dox does not seem to exert any impact on 
endogenous Hoxa2 expression level. In summary, a higher level of Hoxa2 protein was 
observed from the sample harvested from the CG4-SHoxa2 No-Dox group, compared 
with CG4 control groups (Dox and No-Dox) or with Dox treated CG4-SHoxa2 group. In 
contrast, Hoxa2 dramatically decreased in CG4-ASHoxa2 when cultured without Dox. 
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Figure 13. RT-PCR and western blot analysis demonstrate the successful development of 
the two double stable cell lines. A, represents RT-PCR results from the ten sense double 
stable cell clones (I to X) that survived 5 weeks of selection against hygromycin (see 
section 3.11 for RT-PCR procedures). Five micro liters of the PCR products of each 
sample were loaded on a 1% agarose gal. Lane1 wt is CG4-tTA cells, which were used as 
wild-type control. Lane 11, cDNA of Hoxa2 in clone X, was demonstrated to have the 
highest Hoxa2 RNA transcription. B, represents the expression of Hoxa2 at the protein 
level in genetically modified cells. In CG4-SHoxa2 cells, withdrawing Dox led to 
increased level of Hoxa2 expression, whereas CG4-ASHoxa2 cells cultured in the 
absence of Dox showed reduced-Hoxa2 expression.  
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The antibiotic resistance test, RT-PCR, and western blot analysis confirmed the 
successful generation of the double stable cell lines.     
4.6 Morphological characteristics of the genetically modified cells 
             CG4 cells are known to exhibit morphology typical of oligodendrocyte 
progenitors (OPCs) (Louis et al., 1992), which display a bipolar or tri-polar phenotype. 
After the two double stable cell lines were generated, microscopy was utilized to examine 
whether any morphological alterations had occurred in these genetically modified CG4 
cell lines.  
Following transfection of the second plasmid, cells were plated at low density (1 
x 103/cm2) to perform the antibiotic screening. Within 3 weeks, cells that were not 
successfully transfected would not survive, and only those that consistently express 
hygromycin and neomycin resistant genes would show growth. Due to the low density of 
initial cell populations for drug screening, a single cell proliferates, expands and 
eventually grows into a small cell population without any inter-crossing with other cells 
and their descendants. By doing so, cells with a homogeneous genetic background could 
be sub-cultured. We noticed that cell clones containing either sense Hoxa2 (Fig. 14A) or 
anti-sense Hoxa2 (Fig. 14B) exhibited different morphological characteristics during drug 
selection. Cells carrying the sense Hoxa2 containing vector exhibited a bipolar phenotype 
in GM, with long and unbranched processes, similar to that of the wild-type cells. In 
contrast, most of the antisense-Hoxa2 expressing CG4 cells appeared to have round 
nuclei with few processes extending out, even though they were cultured under the same 
selection conditions as sense Hoxa2 expressing cells.  
As the cell clones developed into a size ready for transfer, individual cell clones 
were then passed onto a new culture surface in a 6-well dish to expand the total cell 
population. For CG4 wild-type cells, no obvious phenotype alteration was observed when 
Dox was incorporated in the medium. To further assess cell morphology changes in the 
newly engineered cell lines, cells were cultured at 3x104 per 35mm2 in GM without the 
addition of any selection antibiotics or Dox. Both wild-type CG4 cells (Fig. 14C) and 
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Figure 14. Phenotype of CG4-SHoxa2 (A, D), CG4 wild-type (C) and CG4-ASHoxa2 
(B, E) cells. When performing antibiotic screening, individual cells that contained the 
hygromycin resistant gene survived and gave rise to a cell clone. Images A and B were 
taken three weeks after transfection during the hygromycin selection. After confirming 
the establishment of CG4-SHoxa2 and CG4-ASHoxa2 cell lines, CG4 wild-type (C), 
CG4-SHoxa2 (D) and CG4-ASHoxa2 (E) cells were cultured under the same condition in 
GM. Images C, D and E were taken after cells were plated and cultured in GM (No Dox, 
No hygromycin) for 1 day. Scale bar indicates 25 μm. 
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sense Hoxa2 expressing cells (Fig. 14D) displayed a typical phenotype known for O-2A 
progenitor cells. In comparison, the cells that carried the anti-sense Hoxa2 vector (Fig. 
14E) exhibited multiple short and branched processes, which are distinguishable from the 
long and bipolar processes of the other two cell lines (Fig. 14C, D). These observed 
phenotype alterations are consistent with in vivo findings, where primary OPCs isolated 
from Hoxa2 null mice exhibit multiple relatively shorter and branched processes 
(unpublished data from Dr.Nazarali’s Lab).   
4.7 Over-expression of Hoxa2 promotes the proliferation of CG4-SHoxa2 cells 
Because of limited time, I decided to focus on the impact of up-regulating Hoxa2 
expression on the proliferation and differentiation of CG4 cells, in contrast to the loss-of-
function study (Nicolay et al., 2004b). BrdU uptake assay was employed to investigate 
whether over-expression of Hoxa2 would affect the proliferation of genetically 
manipulated CG4 cells. Both CG4 and CG4-SHoxa2 cells were cultured either with or 
without Dox for 2 or 3 days in appropriate medium, and BrdU was added for the last 2 h 
of incubation. Both CG4 (Dox), CG4 (No Dox) and CG4-SHoxa2 (Dox) cells served as 
controls. Interestingly, CG4-SHoxa2 cells exhibited BrdU uptake at ~49% in the 
presence of Dox and ~59% in the absence of Dox (Fig. 15A). In comparison, the 
proliferation rate of wild-type CG4 cells was not significantly different between Dox and 
No Dox groups (Fig. 15A). Data were collected from 3 repeated studies with evaluation 
of at least 500 cells or 10 scoring fields per experiment. The percent of BrdU+ve cells in 
each field was quantified and subjected to ranking to obtain the median, which was then 
analyzed using nonparametric Kruskal-Wallis method followed by Dunn’s multiple 
comparison test.  
The proliferation rate for CG4-SHoxa2 cells in the absence of Dox was 
significantly higher compared to the three control groups (p<0.001), indicating that over-
expression of Hoxa2 promotes the proliferation rate of CG4 cells. Even with the presence 
of Dox, these genetically modified CG4-SHoxa2 cells exhibited greater BrdU uptake 
capability (p<0.05) compared with two wild-type CG4 cell groups. Although the 
presence of Dox did not appear to alter the level of Hoxa2 protein in CG4-SHoxa2 cells, 
whether the introduction of the ‘Tet-off’ system affects the molecular and cycling events 
of CG4 cell is yet to be determined. Another potential factor is the homogeneity of the  
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Figure 15. Analysis of proliferation rate by BrdU incorporation assay. (A) For CG4 wild-
type cells, when cultured in GM, no significant difference in proliferation rates was 
observed for groups with or without Dox. In contrast, CG4-SHoxa2 cells over-expressing 
Hoxa2 (No Dox) displayed a significantly higher percentage of BrdU uptakes than the 
wild-type CG4 cells and CG4-SHoxa2 cells cultured in the presence of Dox. a, p<0.05, 
compared to C-GM-D and C-GM-N; b, p<0.001, compared to all other groups.  (B) The 
cells were then induced to differentiate to examine whether the increased cell 
proliferation continued during maturation. As shown here, the proliferation rate for all 
four groups decreased. Regardless of this decline, CG4-Shoxa2 cells in the absence of 
Dox exhibit a substantially higher proliferation rate than cells subjected to Dox. a, 
p<0.05, compared to C-2DM-D and C-2DM-N; b, p<0.001, compared to all other cell 
groups; C-wild-type CG4 cells, S-sense Hoxa2 carrying CG4 cells, GM-growth medium, 
2DM-cells grown in differentiation medium for 2 days, D-exposed to Dox, N-not 
exposed to Dox. Experiments were repeated three times, and 10-12 fields were selected 
each time. Each data point represents one field from the total collected fields. The red bar 
in the middle indicates median of the data, and symbol ┬ stands for interquartile range.  
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CG4 cell line used in this project. Due to previous manipulation and sub-cultures, the 
pool of CG4 cells might already contain group of cells at more advanced developmental 
stage; therefore, these sub-group of cells may age faster and be less proliferative. In 
comparison, the CG4-SHoxa2 cells were recently derived from one single progenitor cell, 
thus, each daughter cell would possess the same genetic properties and be at the same 
developmental phase. This assay was repeated on all groups of cells cultured in DM for 2 
days to determine whether the increased proliferation would continue when cells 
differentiated. After two days of incubation to induce cell differentiation, BrdU uptake 
was dramatically reduced for all cell groups, although the CG4-SHoxa2 No-Dox treated 
group retained the highest uptake of BrdU molecule (Fig. 15B). 
4.8 Cells at early developmental stages are proliferative 
To further investigate the identity of BrdU+ve cells in the proliferation study, 
cells were double labelled with BrdU/A2B5, BrdU/O4, or BrdU/GalC. As mentioned 
previously, no GFAP staining was observed here, although O-2A progenitor cells have 
been reported to co-express A2B5 and GFAP antigens in some cases (Wang et al., 1994). 
Thus, further GFAP staining was not carried out for this aspect of the study. Initially, 
each of the four cell groups (CG4-Dox, CG4-No Dox, CG4-SHoxa2-Dox, CG4-SHoxa2-
No Dox) was cultured in GM in two wells of a 6-well dish, with two coverslips per well 
for staining. The two coverslips in the first well were subjected to BrdU/A2B5 and 
BrdU/O4 staining, respectively, whereas the second set of two coverslips were stained 
with BrdU/GalC. GalC staining was not observed in any of the four cell groups when 
they were cultured in GM (data not shown). For CG4 cells, a majority of the BrdU+ve 
cells were also positive for A2B5 labelling, and only a small number of CG4 cells were 
positive for the O4 antibody. Both A2B5 and O4 positive cells were seen to co-localize 
with BrdU staining (O4 data not shown). In comparison, virtually all the CG4-SHoxa2 
cells (either treated with or without Dox) were A2B5+, with only very few scattered 
O4+ve cells detected. Additionally, all the BrdU+ve cells were co-localized with A2B5 
in the CG4-SHoxa2 group cells (Dox, No-Dox) (Fig. 16C, G).  
Cells (CG4, CG4-SHoxa2) were allowed to differentiate in DM for two days 
before being subjected to double immunolabelling with anti-BrdU antibody and OL cell 
lineage maturation markers (A2B5, O4 or GalC). Upon examination, the percent of  
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Figure 16. Double labelling of BrdU (A, E) with A2B5 (B, F) antibody for CG4-Shoxa2 
cells (Dox and No Dox treated). Cells were cultured in GM overnight, and then subjected 
to BrdU incubation. The cells were fixed first, followed by A2B5 staining. BrdU 
immunocytochemistry was performed afterwards. Co-localization of BrdU positive cells 
and A2B5 expressing cells was demonstrated by merging the A and B or E and F images, 
respectively, indicated by yellow (C, G). D and H was the Hoechst staining of the same 
field. Scale bar indicates 100µm. 
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Figure 17. Double labelling of BrdU (A, E) with A2B5 (B, F) in 2DM cultures. After 
two days incubation in DM, one coverslip was subjected to double labelling with anti-
BrdU and anti-O4, and the other one was stained with anti-BrdU and anti-A2B5 (or anti-
GalC). The number of BrdU labelled cells (A, E) decreased significantly compared to the 
cell groups cultured in GM (Fig. 16A, E), either in the presence or absence of Dox. In 
addition, a large portion oF the cells may stop expressing antigen A2B5, as 
immunocytochemical staining revealed substantially fewer A2B5+ve cells (B, F). Scale 
bar indicates 25 µm.  
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Figure 18. Double labelling of CG4-SHoxa2 cells in 2DM cultures with anti-BrdU (A, 
E) and anti-O4 (B, F) antibodies. Immunostaining of OL-cell lineage maturation markers 
revealed that a significant portion of cells may stop producing A2B5 antigen (Fig. 17B, 
F) but start to express O4 (B, F). Scale bar indicates 25 µm. 
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A2B5+ve cells was reduced significantly in all four cell groups, [compare Figure 16 with 
Figure 17 (data only represent CG4-Shoxa2 cells)]. Regardless of the Dox condition, no 
GalC staining was detected in either of the two CG4-SHoxa2 groups. In contrast, a few 
patches of GalC+ve cells were observed in the two wild-type CG4 cell groups, but no 
BrdU+ve staining was seen colocalized with GalC+ve cells. In agreement with previous 
findings (Fig. 15B), much fewer BrdU+ve cells were observed after 2 days incubation in 
DM. Again, a majority of the BrdU positive staining was found colocalized with 
A2B5+ve cells (Fig. 17C, G), whereas only a small percentage of O4+ cells incorporated 
the BrdU (Fig. 18C, G), supporting previous findings reported by Tang et al. (2000).  
4.9 Over-expression of Hoxa2 does not impact the mRNA level of PDGFαR 
Wild-type CG4 cells, in the presence or absence of Dox, demonstrated a 
comparable percentage of BrdU+ve cells, confirming that Dox, by itself, does not impact 
cell proliferation (Fig. 15). Therefore, an up-regulation of Hoxa2 expression in the no 
Dox-treated CG4-Shoxa2 cells likely contributes to the enhanced proliferation rate. Since 
PDGF is a known mitogen for OPCs, and has been shown to increase cell proliferation 
(Engel and Wolswijk, 1996; Baron et al., 2002), we then examined whether the 
expression of PDGFαR in cells is altered when the expression of Hoxa2 gene is up-
regulated. For this purpose, I used RT-PCR to determine the mRNA level of PDGFαR in 
cells at two distinct developmental stages, using β-actin as an internal standard.  
For RNA isolation and preparation, parallel experiments to the BrdU 
incorporation assay were conducted. Cells were subjected to Dox or No Dox, either in 
GM or DM. RT-PCR products were visualized on a 1.5% agarose gel, and the expression 
levels of PDGFαR and beta-actin were quantified with the AlphaImagerTM Gel Imaging 
Software. PDGFαR mRNA signals were normalized to β-actin and the ratios were 
calculated from three repeated RT-PCR experiments. As shown in Fig. 19, the PDGFαR 
receptor gene is expressed at high levels in early progenitors, although no significant 
differences were observed in the Mrna level of PDGFαR among the four examined cell 
groups. After 2 days in DM, the mRNA of PDGFαR expression in more advanced cells 
were slightly reduced (Fig. 19), in agreement with previous findings (Ellison and de 
Vellis, 1994; Garcion et al., 2001). However, the RT-PCR analysis did not reveal any 
statistically significant differences in the mRNA of PDGFαR among four groups of cells. 
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Figure 19. RT-PCR analysis of PDGFαR mRNA expression in CG4 and CG4-SHoxa2 
cells. For RNA preparation, all cell groups followed the same protocol as used in the 
proliferation assay. C-GM-D, CG4 cells were cultured in GM treated with Dox; C-GM-
N, CG4 cells were cultured in GM without Dox; 2DM, cells were grown in DM for 2 
days. Studies were based on three independent batches of RNA preparations. 
AlphaImagerTM Gel Imaging Software was utilized to obtain the intensity of each band 
on 1.5% agarose gel. The ratio between PDGFαR and β-actin was then calculated and 
subjected to one-way ANOVA with Tukey’s multiple comparison post hoc tests in 
GraphPad Prism. Histogram bars represent the mean value from three repeated 
experiments with standard diviation error.   
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4.10 Effect of enhanced Hoxa2 level on the differentiation of CG4-SHoxa2 cells 
4.10.1 Immunocytochemistry study and quantitative analysis 
My next aim was to examine if up-regulated Hoxa2 would impact on the 
developmental course of CG4 cells. Although immunohistochemical studies of the OL 
lineage in the developing spinal cord suggest OPCs progress normally in the absence of 
Hoxa2 (Nicolay et al., 2004b), a quantitative analysis has not been carried out before. 
Thus, I decided to monitor the differentiation of CG4 and CG4-SHoxa2 cells by precisely 
determining the percentage of specific subpopulations - A2B5-expressing cell subgroup, 
O4-expressing cell subgroup and GalC-expressing cell subgroup - at distinct 
developmental stages in differentiation cultures.  
To stimulate cell differentiation, cells were seeded at 4x105 cells per well and 
incubated in DM after an initial 16-h culture in GM (see Materials and Methods 3.1). For 
cells in wells 1, 2 and 3 (Fig. 7), the concentration of Dox was sustained at 2 µg/mL, but 
the cells in wells 4, 5 and 6 were kept Dox free after seeding. By removing Dox, CG4-
SHoxa2 cells cultured in the wells 4, 5 and 6 were allowed to over express Hoxa2 during 
the differentiation study. Regardless of the presence or absence of Dox, both groups of 
CG4-SHoxa2 cells underwent differentiation toward mature OL-like morphology, and 
began to express late stage OL-lineage markers O4 and GalC (Fig. 20), similar to that 
observed in wild-type CG4 cells (Fig. 8 and Fig. 9). Thus, I came to the conclusion that 
over-expression of Hoxa2 does not block the OL-like maturation of CG4-SHoxa2 cells in 
DM.  
To quantify A2B5+ve, O4+ve and GalC+ve cell populations in each cell group as 
the cells differentiated, ten to twelve fields of each coverslip were selected to best 
represent the staining results. In each field, the percentage of positive cells (e.g. 
A2B5+ve) was calculated based on Hoechst counterstain. The data collected from three 
repeated experiments were subjected to Kruskal-Willis ranking test followed by Dunn's 
multiple comparison tests.  
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Figure 20. Differentiation of CG4-SHoxa2 cells occurred in the presence (A, B, C) and 
absence of Dox (D, E, F). Similar to wild-type CG4 cells (Fig. 9), genetically modified 
cells were induced to differentiate by switching the GM to DM. After three days in DM, 
GalC+ve (A, D) and O4+ve cells (B, E) were observed in both cell groups, supplemented 
with or without Dox. C and F are the Hoechst nuclear staining of the same field. Scale 
bar indicates 25 μm.    
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In the 2DM cultures, very few GalC+ve cells were observed in CG4-SHoxa2 cell 
groups, either in the presence or absence of Dox (data not shown). In contrast, several 
patches of GalC+ve staining were seen in CG4 cell groups. Therefore, I only assessed the 
proportion of A2B5+ve and O4+ve cells in these four cell groups. Similar to what had 
been demonstrated in the proliferation assays, the CG4-Dox group and CG4-No Dox 
group displayed a comparable percentage of cells expressing OL cell markers, A2B5 and 
O4. For CG4-SHoxa2 cells, the Hoxa2 up-regulated cell group (No Dox) showed 
significantly higher percentage of A2B5+ve cells (>30%, p<0.05) than those in the wild-
type CG4 cells and in the Dox-treated CG4-SHoxa2 group (Fig. 21A), whereas the 
median of A2B5+ve% in Dox treated CG4-SHoxa2 cells was not statistically different 
from those in the wild-type CG4 groups. As for the percentages of O4+ve cell population, 
no statistically significant differences were observed among the four cell groups. 
After one additional day in DM (3DM), CG4-SHoxa2 cells, in the absence of 
Dox, exhibited similar amounts of A2B5+ve%, O4+ve% and GalC+ve% cells as the 
Dox-treated CG4-SHoxa2 cell group (Fig. 22). The two CG4-SHoxa2 cell groups were 
now noticeably at a less advanced stage, since they displayed a significantly higher 
percentage of A2B5+ve cells (Fig. 22A) and much lower percentage of GalC+ve cells 
(Fig. 22C) when compared to wild-type CG4 cells. However, no statistically significant 
differences in the percentage of O4+ve cells were found among these four cell groups 
(Fig. 22B).  
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Figure 21. Characterization of the portion of A2B5+ve and O4+ve subpopulations in 
each of the four cell groups at 2 DM. Twelve fields were selected for each coverslip to 
represent total cell population on the coverslip and total cell number for each field was 
established by counting Hoechst-stained nuclei. In each field, cells that were A2B5+ or 
O4+ were summarized in percentage and results were analyzed for statistical significance 
by using non-parametric Kruskal-Willis ranking followed by Dunn’s multiple 
comparison tests with the aid of GraphPad Prism Software. C, CG4 cells; S, CG4-
SHoxa2 cells; 2DM, indicates 2 days of culture in DM. D, cells were exposed to Dox; N, 
cells were cultured in the absence of Dox. a, p<0.05 when compared to all other groups 
of cells. Experiments were repeated three times, and 10-12 fields were selected each time. 
Each data point represents for one field from the total collected fields. The red line in the 
middle indicates median of the data, and symbol ┬ stands for interquartile range. 
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Figure 22. The proportion of each OL-lineage marker labelled subpopulation                       
in four cell groups at 3DM. The data of each cell group was compared using Kruskal-
Wallis ranking, followed by Dunn’s multiple comparison tests. CG4 cells either treated 
with or without Dox displayed nearly identical percentages for each marker labelled 
subpopulation. At this time point, the proportion of A2B5, O4 and GalC labelled 
subgroup cells in No Dox-treated CG4-SHoxa2 did not significantly different from those 
of the Dox-treated CG4-SHoxa2 group. However, when compared with wild-type CG4 
groups, both two CG4-SHoxa2 cell groups showed statistically higher percentage of 
A2B5+ve cells and lower percentage of GalC+ve cells. C or S, indicates CG4 or CG4-
SHoxa2 cell lines. 3DM represents 3 days in DM culture. D, Dox-treated; N, No Dox-
treated. Superscripts a, b indicate statistical significance when compared with C-3DM-D 
and C-3DM-N groups, p<0.05. Experiments were repeated three times, and 10-12 fields 
were selected each time. Each data point represents for one field from the total collected 
fields. 
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4.10.2 Semi-quantitative RT-PCR 
Immunocytochemistry reveals the presence of gene products at the protein level. 
Conversely, it can also produce false results if many parameters are not adequately 
controlled for and tested (Gordon and Rekhter, 1993). In addition, background noise may 
interfere with cell counting and quantifying obtained data may be difficult. In 
comparison, recent techniques highlight the advantages of RT-PCR over 
immunocytochemistry with respect to quantification and sensitivity. Therefore, semi-
quantitative RT-PCR analysis was used as an alternative technique for further 
investigating the impact of up-regulated Hoxa2 on the differentiation of CG4-SHoxa2 
cells, by examining the expression of two OL-lineage late stage markers, ceramide 
galactosyltransferase (CGT) (Fig. 23) and myelin basic protein (MBP) (Fig. 24). To 
validate the performance of RT-PCR in each reaction, β-actin was utilized as an internal 
control. 
CGT is a key enzyme that catalyzes the final step in the biosynthesis of GalC and 
is frequently used as late stage marker for OLs (Gokhan et al., 2005). CGT has been 
reported to be first expressed around the time that myelination begins (Schulte and 
Stoffel, 1993). Although Tokumoto et al. (1999) have reported the presence of CGT 
mRNA and protein in OPCs isolated from the optic nerve of newborn rats, adding to the 
confusion, Gokhan and coworkers (2005) have suggested that the transcription of CGT 
begins only after the O4 marker is expressed in OL-lineage cells derived from dorsal 
forebrain of embryonic mice. In this study, we characterized the expression profile of the 
mRNA of CGT in a dynamic manner (Fig. 23A). CGT mRNA were readily detected at 
the early progenitor stage when the four groups of cells were maintained in GM, but the 
CGT Mrna level in Hoxa2 over-expression cell group was significantly lower (p<0.05, 
Fig. 23B). A considerable increase in the mRNA of CGT was observed in wild-type CG4 
cells (Dox- and No Dox-treated groups) after two days in DM, but the mRNA levels 
detected at 3DM subsequently declined to the level observed in GM (Fig. 23). Similarly, 
CG4-SHoxa2 cells in the presence of Dox reacted in the same manner as wild-type CG4 
groups, exhibiting comparable CGT mRNA level and change during the differentiation 
study. In contrast to the other three cell groups, CG4-SHoxa2 cells in the absence of Dox,  
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Figure 23. Expression profile of CGT mRNA in CG4 and CG4-SHoxa2 cells. Mean 
value of CGT-mRNA/β-actin-mRNA ratio with an error bar of standard deviation (n=3) 
is presented. A is one of the three RT-PCR results evident on a 1.5% agarose gel. B. The 
density ratios between CGT and β-actin in the four cell groups at each time point were 
subjected to one-way ANOVA followed by Tukey’s multiple comparison post tests. +, 
Dox-treated; -, No Dox-treated. a, statistical significance when compared with C-3DM-D, 
C-3DM-N and CG4-SHoxa2-Dox cell groups, p<0.05.  
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where exogenous Hoxa2 expression is allowed, displayed statistically less CGT mRNA 
both in GM and at day 2 in DM. In addition, the presence of CGT mRNA in the Hoxa2 
up-regulated cell group continued to increase and reached the highest level in DM at day 
3. 
Although MBP is recognized as a late stage marker for OL and the presence of 
the MBP protein, in general, announces terminal maturation, several lines of evidence 
demonstrated that the mRNA of MBP is present in OPCs (Ye et al., 2003; Gokhan et al., 
2005). Our data lend support to previous findings, where the mRNA of MBP was 
observed in both CG4 cells and CG4-SHoxa2 cells when cultured in GM (Fig. 24A). In 
addition, it appears that the mRNA level of MBP in CG4 cell groups (Dox-treated, No 
Dox-treated) increased steadily as cell differentiation advanced, similar to the pattern of 
MBP mRNA detected in lineage-restricted neuronal-OL cells (Gokhan et al., 2005). In 
the CG4-SHoxa2 cell line, a gradual increase of MBP mRNA level was observed as cell 
differentiates, either in the presence or absence of Dox. Notably, Hoxa2 up-regulated 
CG4-SHoxa2 cells displayed significantly lower MBP transcripts than those shown in the 
other three groups (p<0.001), and they in the presence of Dox still contained less MBP 
mRNA than the two wild-type CG4 cell groups (p<0.05).  
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Figure 24. Expression profile of MBP mRNA in CG4 and CG4-SHoxa2 cells. Mean 
value of CGT-mRNA/β-actin-mRNA ratio with an error bar of standard deviation (n=3) 
is presented. A is one of the three RT-PCR results evident on a 1.5% agarose gel. B. The 
density ratios between MBP and β-actin in the four cell groups at each time point were 
subjected to one-way ANOVA followed by Tukey’s multiple comparison post tests. +, 
Dox treated; -, No Dox treated. a, significance of p≤0.05 compared with CG4-Dox and 
CG4-No Dox groups; b, significance of p≤0.001 compared to all other groups. 
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V DISCUSSION 
One of the most common control mechanisms underlying the development of OLs 
involves the nuclear DNA-binding TFs, which regulate the transcription of downstream 
genes at the level of initiation. Therefore, identifying key TFs and illustrating their role 
during oligodendrogenesis will greatly advance our knowledge in understanding cell fate 
specification and the programming of OL differentiation. Clustered Hox genes are TFs 
known to play a central role in current models of both the establishment of body axes, as 
well as cell fate determination in multiple organs (reviewed in Keynes and Krumlauf, 
1994; Akin and Nazarali, 2005). In recent studies, our laboratory reported that Hoxa2, 
Hoxb4, and Hoxd1 genes, members of the Hox transcription family, are expressed in OLs 
(Hao et al., 1999; Nicolay et al., 2004a, b; Booth et al., 2007). Arenkiel and co-workers 
(2003, 2004) revealed that majority of r4 originated Hoxb1-expressing neural crest cells 
give rise to myelinating cells in the peripheral nervous system. Together, the above 
findings raise the following question: do Hox genes, or particularly Hoxa2, play a role 
during oligodendrocyte development? And if so, what is the nature of this role? In this 
context, the aim of this research project was to investigate the role of Hoxa2 gene in 
regulating the development of the OL-lineage cells.  
In the course of this work, I established the Tetracycline regulated inducible 
expression systems in CG4 cells, where Hoxa2 protein can be elevated (CG4-SHoxa2) or 
reduced (CG4-ASHoxa2). We showed that CG4-SHoxa2 cells, either in the presence or 
absence of Dox, displayed a typical morphology of O-2A progenitor cells, as the CG4 
cell line does. The CG4-ASHoxa2 cells, on the contrary, exhibited somewhat altered 
morphology under the same culture condition as CG4 and CG4-SHoxa2 cells, showing 
multiple shorter processes instead of long and smooth processes. To complement the 
loss-of-function study carried out by Nicolay et al. (2004b), I focused on analyzing the 
impact of up-regulated Hoxa2 level on the proliferation and differentiation of CG4-
SHoxa2 cells. The BrdU uptake data suggests a positive correlation between up-regulated 
Hoxa2 expression and increased cell proliferation. Further, we demonstrated that 
overexpression of Hoxa2 does not block the differentiation of CG4-SHoxa2 cells, but the 
mRNA expression pattern of CGT and MBP, two OLs late stages markers, indicated that 
the transcriptions of CGT and MBP were delayed in No Dox-treated CG4-SHoxa2 cells. 
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5.1 Evaluation of the Tet system  
Exogenous and switchable control of the synthesis of target genes has become a 
popular requirement for both studies of gene function and therapeutic purposes. One 
particular attempt reported the development of a two vector-based tetracycline (Tet, or its 
analogue Dox) regulated system for on-off switching of a transgene (Harding et al., 
1998), which can be utilized in a tissue/cell specific, dose dependent manner. Recently, 
the ‘tet-off’ has been successfully applied in a variety of models (Miyazaki et al., 2005) 
including the CG4 cell line (Ralph et al., 2000; Magy et al., 2003). The key step in 
establishing the ‘tet-off’ system was selection of two sequential stable cell clones which 
ensured long-term control of gene expression since the transgene was integrated into the 
chromosomes of the host.  
The first vector, pTet-off, contains a neomycin-resistance (G418) cassette for 
selection in eukaryotic cells; the second vector encoding the target insert carries a 
hygromycin resistance marker. Individual kill curves for antibiotics Dox, G418 and 
hygromycin, were established for the CG4 cells and a suitable concentration was 
determined before application to the new cell line. For Dox, a final concentration 2 
µg/mL was chosen based on cytotoxicity evaluation (Materials and Methods 3.3). In 
addition, the western results (Fig. 13) obtained for both CG4-SHoxa2 cells and CG4-
ASHoxa2 cells confirmed the proper dosage of Dox, thus avoiding any significant 
leaking of expression or cytotoxic effects on cells.  
To further eliminate any impact from Dox and to exclude any positional effects 
from gene integration into the host genome, I divided each cell line into two groups, one 
cultured with Dox and the other without, as shown in Fig. 8. Therefore, in addition to 
wild-type CG4 cells, Dox-treated CG4-SHoxa2 cell group also serve as a control. In all 
the proliferation and differentiation assays, wild-type CG4 cells treated with Dox or 
without Dox behaved in the same manner, as expected. In theory, CG4-SHoxa2 cells 
should behave similarly to wild-type CG4 cells when grown in the presence of Dox, since 
the level of Hoxa2 remains the same as that in wild-type CG4 cells (Fig. 13). 
Interestingly, our data shows that Dox-treated CG4-SHoxa2 cells displayed statistically 
significant differences from the wild-type CG4 cells, in the BrdU uptake study and the 
differentiation investigations. The observed differences might be due to position effects 
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from the integration site. Alternatively, it may be because the engineered cell line 
contains a much purer population with highly proliferative progenitor cells after cloning 
selections than the wild-type CG4 cell line.   
During the selection of double stable cell clones, both G418 (100µg/mL) and 
hygromycin (200µg/mL) were present in the culture. In contrast, neither of these drugs 
was added for the BrdU assay or differentiation assays, to eliminate any cytotoxic effects 
on CG4-SHoxa2 cells. Due to a short half-life and light sensitivity of doxycycline, all 
Dox-treated cell groups were fed every other day with fresh medium containing newly 
added Dox to ensure proper inhibition of Hoxa2 transcription. 
5.2 Homogeneity and stability of selected cell line 
Stable cell lines offer a number of desirable attributes over a transiently 
transfected test system, including an inherent degree of homogeneity, which is 
particularly important for cell based function assays. In the protocol here, a low cell 
density was combined with suitable selection drugs; thus, individual cell clones which 
appeared after 10~15 days selection were derived from virtually the same single cells. In 
comparison, the wild-type CG4 cells used in this study included a small portion of more 
mature-looking cells, which possibly resulted from frequent manipulations and exhausted 
passages. Additionally, during the construction of CG4-SHoxa2 and CG4-ASHoxa2 cell 
lines, Dox was not added to the medium until two days after the vector was introduced 
into the cells, which might have an impact on the cycling and differentiation of the cells. 
Consequently, one of the limitations of my experimental work is the potentially inherent 
stage-related difference among wild-type CG4, CG4-SHoxa2 and CG4-ASHoxa2 cell 
lines. Nevertheless, it is of interest to compare the results regarding cell morphology and 
viability from the CG4-ASHoxa2 cell line with that observed in CG4-SHoxa2 cell line. 
These two cell lines went through similar genetic manipulations differing only with 
different insert integrated into the host genome. The CG4-SHoxa2 cells maintained 
progenitor-like morphology and actively proliferated in the GM, whereas CG4-ASHoxa2 
cells were comparatively slow in cell proliferation, poor in attachment, and featured a 
more mature cell phenotype. Given the above data, I conclude that Hoxa2 participates in 
regulating the maturation of CG4 cells.  
Stability is another issue in stable cell line construction. The cells endured 
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selective pressure from both G418 and hygromycin after the second transfection until 
they proliferated from one single cell to sufficient amounts, which generally took 
approximately 4 weeks. The western blot analysis was performed after 6 weeks selection 
(Fig. 13). In principle, a stable cell line should be able to express a transgene at a constant 
level indefinitely. However, stable expression often can be “silenced” or cease after the 
cells has been cultured for some time, because cells can recognize and silence multiple 
copies of genes, presumably as part of a defense mechanism against mass replication by 
viruses (Garrick et al., 1998). This suppression phenomenon can be a potential limitation 
for application of these constructed cell lines over the long term.  
5.3 Effect of over-expression of Hoxa2 on cell proliferation  
Previous data from our lab has revealed the presence of Hoxa2, Hoxb4 and Hoxd1 
in OL-lineage cells in vivo (Nicolay et al., 2004a, b; Booth et al., 2007). The study I 
present here shows Hoxa2 expression throughout the development course of CG4 cells, a 
derivative of O-2A cells isolated from rat brain. CG4 cells proliferate and remain in the 
progenitor stage in the presence of mitogens secreted by the neuronal B104 cell line. 
Potentially, the immortalizing mitogens for CG4 cells can be bFGF and PDGF, the 
combination of which has been demonstrated to arrest O-2A cells at the early stage 
(Bögler and Noble, 1994). This cell line has served as a useful model to study the many 
aspects of OLs without introducing immortalizing oncogenes. Thus, the detection of Hox 
genes in CG4 cells is not due to any tumorigenic transformation, but rather reflects the 
genetic property of OLs.  
The BrdU uptake experiments demonstrated that overexpression of Hoxa2 
elevates the proliferation rate of CG4-SHoxa2 cells compared with the Dox-treated CG4-
SHoxa2 cell group and wild-type CG4 cells. Consistent with this BrdU uptake assay, 
CG4-SHoxa2 cells with up-regulated Hoxa2 level contained a significantly higher 
percentage of A2B5+ve cells at 2DM when the four groups of cells were triggered to 
differentiate (Fig. 21A). It is, therefore, of interest to investigate by what mechanism 
Hoxa2 increases the proliferation of cells. Mitogen PDGF is one of the key factors known 
to promote the survival and proliferation of OLs, possibly, by increasing cyclin D1 and 
repressing the synthesis of p27/kip1 (Winston et al., 1996; Agrawal et al., 1996). Since 
the mitogens presented in the medium were of the same concentration in four cell groups, 
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I wondered if the level of receptor for mitogen PDGF expressed on CG4-SHoxa2 cells 
was elevated by overexpressing Hoxa2, rendering the cells more sensitivity to PDGF. 
Two isoforms (α and β) of PDGF receptor have been identified (Claesson-Welsh, 1994), 
but only PDGFαR is expressed in O-2A progenitor cells (McKinnon et al., 1990; Ellison 
and de Vellis, 1994). Thus, I only examined the mRNA of PDGFαR in the RT-PCR study. 
In The RT-PCR results showed that as the cells differentiate, the transcription of 
PDGFαR is down-regulated in all cell groups, but no significant difference was detected 
among No Dox-treated CG4-SHoxa2 cells and the other three groups regarding the 
transcription level of PDGFαR, indicating that Hoxa2-regulated cell proliferation may be 
independent of the PDGF signalling pathway. Nevertheless, further investigations of 
PDGFαR at the protein level are required to make a firm conclusion. 
Alternatively, a question to be asked is whether Hoxa2 directly interacts with the 
cell cycling machinery. Recently, Hox/HOX genes have been shown to contribute to 
tumorigenesis or function as indicators of tumor when aberrantly expressed (Del Bene 
and Wittbrodt, 2005). This has led to recent progress made in understanding and 
explaining the complex interactions between Hox/HOX TFs and components of the cell 
cycle machinery. One of the best examples for clustered Hox genes is the identification 
of p21/kip1, a cyclin-dependent kinase inhibitor (CKI), as the direct target of HOXA10 
(Bromleigh and Freedman, 2000) in differentiating myelomonocytic cells. Bromleigh and 
Freedman (2000) further demonstrate that overexpression of HOXA10 in U293 cells leads 
to arrest in G1 phase and subsequent differentiation to the monocytic cell type, probably 
via activation of p21 transcription by HOXA10 protein. Similarly, Gabellini and co-
workers (2003) suggest that HOXC10 has the potential to influence mitotic progression 
through ubiquitin mediated proteolytic destruction. Furthermore, geminin, a cell-cycle 
regulator during neural differentiation has been shown to interact with Hox proteins in 
Xenopus, preventing Hox proteins from binding to DNA, and thus inhibiting Hox-
dependent transcriptional activation (Kroll et al., 1998). Although no direct evidence 
suggesting a direct interplay between the Hoxa2 gene and cell cycling machine has been 
shown, it is important to test this hypothesis in vertebrate cell models, including OLs 
from rodents.  
At 3DM, to our surprise, the differences seen at 2DM between Dox-treated and 
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No Dox-treated CG4-SHoxa2 cells diminished, particularly regarding the percentage of 
A2B5+ve cells. Is it because the cells with up-regulated Hoxa2 level became less 
proliferative after 2DM? Or had some other factors began to play a role in No Dox-
treated CG4-SHoxa2 cell group, suppressing cell proliferation in favor of cell 
differentiation? Since the percentages of GalC+ve cells in two CG4-SHoxa2 cell groups 
appear the same, it is more likely that the proliferation rate in No Dox-treated CG4-
SHoxa2 cells slowed down. One of the possible factors that slowed down the elevated 
proliferation rate of CG4-SHoxa2 cells (No-Dox) could be the cell density within the 
culture dish. Zhang and Miller (1996) observed that when primary OPCs cultured at 
higher concentration displayed more advanced morphology. In my study, with enhanced 
proliferation in CG4-SHoxa2 (No-Dox) cells, the cell density in this group was higher 
than the other groups, which may have limited cell proliferation and promoted the 
differentiation of precursor cells in this particular cell group.  
5.4 Impacts of up-regulated Hoxa2 level on cell differentiation  
Whether the intrinsic timer in OPCs primarily controls the cessation of 
proliferation, the onset of differentiation, or both, is not certain. After demonstrating 
Hoxa2 promotes the proliferation of CG4-SHoxa2 cells, the next objective was to 
examine if Hoxa2 impacts the cell maturation course after cell cycle exit. By utilizing 
immunocytochemistry, I attempted to determine the pace of cell advancement in both 
Dox-treated and No Dox-treated CG4 and CG4-SHoxa2 cells. If the differentiation in all 
four cell groups proceeded at the same pace, they would have comparable proportions of 
cells expressing a particular staged marker (A2B5, O4, and GalC).  
Notably, not all the cells exit cell cycling and start to differentiate immediately 
upon medium change, as a significant amount of A2B5+ve cells were detected at both 
2DM and 3DM in all four cell groups (Fig. 21 and 22). This might be due to the fact that 
not all the cells are at the G1. Additionally, during progression from progenitor cells 
(A2B5-stage) to the late-progenitor cells (O4-stage), cells remain proliferative, as O4+ve 
cells are still able to incorporate BrdU molecules (Fig. 18). Although CG4-SHoxa2 cells 
with up-regulated Hoxa2 showed higher percentage of A2B5+ve cells at 2DM than the 
other three cell groups, this might be due to elevated proliferation rate of these cells. 
Moreover, no statistically significant differences were observed among the four cell 
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groups regarding the percentage of O4+ve cells, and the Dox-treated and No Dox-treated 
CG4-SHoxa2 cells displayed comparable cell counts at day 3 in DM. Thus, it appears that 
Hoxa2 does not affect the maturation programming of the CG4-SHoxa2 cells.  
On the other hand, two potential factors may have confounded the 
immunocytochemistry study. Firstly, the increased cell proliferation resulted in a higher 
cell density in No Dox-treated CG4-SHoxa2 cell group, which might suppress the 
expansion of OPCs and lead to accelerated cell maturation. Another factor to consider is 
the nature of the O4-expressing cells. Although the generation of cell surface antigens 
follows a temporal order, there are overlaps between each stage, as shown in Figure 1. 
Consequently, the O4-expressing cell population can consist of cells at very distinct 
stage, and only observing the percentage of O4+ve cells leaves detailed but important 
differences uncovered. 
To overcome the drawbacks discussed in the previous paragraph, I decided to 
employ RT-PCR analysis to examine the expression pattern of CGT and MBP, which are 
generally used as late OL developmental markers. The advantage of utilizing semi-
quantitative RT-PCR is that by measuring the mRNA level, we can define the 
developmental stage of the whole cell group without having to consider the stage of 
individual cells. Interestingly, RT-PCR analysis of the expression of MBP and CGT 
strongly indicated that cell differentiation may be hindered when Hoxa2 is over-
expressed in CG4-SHoxa2 cells. The transcription of CGT in the current study displayed 
a dynamic pattern in CG4 and Dox-treated CG4-SHoxa2 cells, which lends support to 
previous findings suggesting a similar dynamic transcription pattern of CGT in rodent 
brain (Garbay and Cassagne, 1994; Yaghootfam et al., 2005). Intriguingly, the CG4-
SHoxa2 cells (No-Dox) displayed significantly lower level CGT mRNA at GM and 
2DM, and a much different pattern of CGT expression during the same study period in 
the Hoxa2 up-regulated CG4-SHoxa2 cell group.  
The CGT enzyme is responsible for catalyzing the final step in GalC synthesis; 
therefore, it is possible that a dramatic increase of the CGT mRNA level is required 
before terminal differentiation in OL-lineage cells. The distinct pattern of CGT mRNA in 
Hoxa2 up-regulated CG4-SHoxa2 cells indicates a delay in the differentiation of this 
group of cells. What was surprising is that I did not observe any substantial variance in 
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the GalC staining between the two CG4-SHoxa2 groups. Further, Dox-treated CG4-
SHoxa2 cells contained much lower percentage of GalC+ve cells compared to wild-type 
CG4 cell groups, despite the fact that these three groups showed similar CGT mRNA 
expression levels and pattern. It will be important to investigate whether CGT mRNA 
level correlate with its enzyme activity regarding the synthesis of GalC protein. 
Furthermore, to fully interpret the data it will be necessary to continue monitoring the 
transcription of CGT in No Dox-treated CG4-SHoxa2 cells, and to examine the 
proportion of GalC+ve cells in two CG4-SHoxa2 cell groups after 3DM.   
The MBPs, which function as membrane adhesion molecules, constitute 30% of 
all myelin proteins in the CNS. Rodent MBP is encoded by a single gene composed of 
seven exons. Varied RNA slicing is known to result in different MBP isoforms in rodents 
(de Ferra et al., 1985): 21.5Kd, which contains all seven exons; 18.5kD, the most 
predominant isoform where the exon II is deleted; 17kD, where exon VI is missing; and 
14kD, which lacks both exons II and VI. The primers used in my study detect a 176 
fragment that spans exons 4 and exon 5, and are able to detect all the isoforms described 
above. Previous studies have demonstrated the presence of MBP mRNA and proteins in 
cultured rat OLs obtained from various tissues (Mirsky et al., 1980; Zeller et al., 1985), 
and have revealed a developmental regulation of MBP in dispersed brain cultures in the 
absence of myelin formation (Zeller et al., 1985). Although MBP proteins are produced 
immediately before the onset of myelination, several lines of evidence indicate MBP can 
be detected in OPCs at mRNA level, preceding the synthesis of the protein (Ye et al., 
2003; Gokhan et al., 2005; Wei et al., 2005). This could explain why results from RT-
PCR reveal MBP mRNA in undifferentiated CG4 and CG4-SHoxa2 cells, while few 
MBP+ve cells were observed in the immunostaining studies. As the differentiation 
progresses, the mRNA of MBP gradually increased in all four cell groups, in agreement 
with the findings reported by other groups (Gokhan et al., 2005; Wei et al., 2005). 
However, the Hoxa2 up-regulated CG4-SHoxa2 cell group consistently displayed 
significantly lower levels of MBP mRNA among the four cell groups (GM, 2DM, 3DM), 
further implying a delay of cell maturation in this particular cell group. It is, therefore, 
concluded that Hoxa2 does play a role in both proliferation and differentiation of the 
CG4-SHoxa2 cell line.  
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5.5 Future directions 
In the present work, I used the gain-of-function approach to investigate the role of 
Hoxa2 in CG4-SHoxa2 cells particularly focusing on the impacts of elevated Hoxa2 level 
on the proliferation and differentiation of cells. The data collected by 
immunocytochemistry and RT-PCR in the differentiation study will be useful for 
interpreting the role of Hoxa2 in OL-lineage cells, however, limitations exist in these 
studies. The first concern is the time length of the differentiation study. The cells were 
only allowed to differentiate for 3 days in DM till they reached the early GalC stage. The 
experiments did not go beyond three days because of poor cell attachment. It is important 
to overcome the culture problem in order to examine the differentiation of CG4-SHoxa2 
cells at much later stages, to fully describe the expression patterns of GalC and MBP 
proteins during terminal maturation. In addition, quantitative real-time RT-PCR is 
suggested to provide more convincing data in the study of the transcriptions of PDGFαR, 
CGT and MBP.  
Since recent evidence implies a link between some Hox genes and cell cycling 
machinery, it is of significant interest to investigate if any components of the cell cycling 
machinery acts as the downstream target of Hoxa2 gene or participates in Hoxa2-induced 
transcriptional cascade. It may be promising to focus on investigating the relationship 
between Hoxa2 and CDK inhibitors, member of which has been shown to be directly 
regulated by other Hox gene (Bromleigh and Freedman, 2000), and can activate the 
promoter of mbp gene in CG4 cells (Miskimins et al., 2002). Increasing evidence from 
the study of neoplasm and hematopoiesis has suggested a pivotal link between the 
processes of cell proliferation and differentiation and Hox genes, as discussed in the 
literature review section (II). It may, therefore, be worthwhile to explore this relationship 
in OL-lineage cells. Another rationale for this idea came from the studies of retinoic acid 
(RA). It is well known that RA influences the expression of many Hox genes in multiple 
developing systems (Marshall et al., 1992, 1996). Recently, RA is also shown to increase 
the expression of two CDK inhibitors, p15 and p21, at both the mRNA and protein level 
in murine neural cells (Wang et al., 2005), and to regulate the proliferation and 
differentiation of OL-lineage cells (Noll and Miller, 1994). It is possible that there are 
molecular links between RA, Hox genes and cell cycling components, as has been 
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proposed by Martinez-Ceballos et al. (2005), where they suggest Hoxa1 protein acts as a 
repressor of RA-induced endodermal differentiation of ES cells in vitro. Given these 
findings, one interesting topic to investigate in the future is whether Hox genes, in 
particular Hoxa2, play a role in regulating OLs development by participating in the RA-
induced signalling pathway.   
In addition, further experiments that characterize migration, apoptosis and 
myelination of CG4-SHoxa2 cells are needed. After examination of CG4-SHoxa2 cells, 
parallel investigations on CG4-ASHoxa2 cells, where the expression of Hoxa2 is down-
regulated, need to be carried out. Besides Hoxa2 gene, Hoxb4 and Hoxd1 are also 
reported to be expressed by OL-lineage cells in vivo (Nicolay et al., 2004a; Booth et al., 
2007). Do they have overlapping roles in OLs to ensure the proper progress of the cell 
development? Or are the expressions of Hox genes temporally regulated along with the 
course of a cell intrinsic timer, as suggested for the HOXB cluster genes in lymphocytes 
(Care et al., 1994; Quaranta et al., 1996)? Detailed examinations of the expression profile 
of each Hox gene in oligodendrogenesis are required to answer the above questions. 
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Appendix I MAP OF THE pTet-off VECTOR (Clontech) 
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Appendix II MAP OF THE pTRE2hyg2-Myc VECTOR (Clontech) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix III RESULTS OF NON-PARAMETRIC TEST FOR  
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BrdU UPTAKE DATA IN GM AND 2DM 
 
 
Kruskal-Wallis test of BrdU+ve% in GM 
  P value P<0.0001  
  Exact or approximate P value? Gaussian Approximation 
  P value summary ***  
       Do the medians vary significant (P < 0.05) Yes  
  Number of groups 4  
  Kruskal-Wallis statistic 52.45  
Dunn's multiple comparison test Difference in rank sum P value 
  C-GM-D vs C-GM-N 6.654 P > 0.05 
  C-GM-D vs S-GM-D -23.17 P > 0.05 
  C-GM-D vs S-GM-N -58.72 P < 0.001 
  C-GM-N vs S-GM-D -29.82 P < 0.05 
  C-GM-N vs S-GM-N -65.38 P < 0.001 
  S-GM-D vs S-GM-N -35.56 P < 0.001 
 
 
Kruskal-Wallis test of BrdU+ve% in 2DM 
  P value P<0.0001  
  Exact or approximate P value? Gaussian Approximation 
  P value summary ***  
  Do the medians vary significant(P < 0.05) Yes  
  Number of groups 4  
  Kruskal-Wallis statistic 52.45  
Dunn's multiple comparison test Difference in rank sum P value 
  C-GM-D vs C-GM-N 6.654 P > 0.05 
  C-GM-D vs S-GM-D -23.17 P > 0.05 
  C-GM-D vs S-GM-N -58.72 P < 0.001 
  C-GM-N vs S-GM-D -29.82 P < 0.05 
  C-GM-N vs S-GM-N -65.38 P < 0.001 
  S-GM-D vs S-GM-N -35.56 P < 0.001 
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Appendix IV RESULTS OF ONE WAY ANOVA TEST FOR 
RT-PCR DATA OF PDGFαR TRANSCRIPTION 
 
One-way ANOVA test  for RT-PCR data of PDGFαR in GM 
  P value 0.2662   
Are means significant different? (P < 0.05) No   
  Number of groups 4   
  F 1.591   
  R squared 0.3737   
ANOVA Table SS df MS 
  Treatment (between columns) 0.002625 3 0.000875 
  Residual (within columns) 0.0044 8 0.00055 
  Total 0.007025 11  
No post tests. P > 0.05    
 
 
One-way ANOVA test for RT-PCR data of PDGFαR in 2DM 
  P value 0.2366   
 Are means significant different? (P < 0.05) No   
  Number of groups 4   
  F 1.737   
  R squared 0.3944   
ANOVA Table SS df MS 
  Treatment (between columns) 0.000825 3 0.000275 
  Residual (within columns) 0.001267 8 0.0001583 
  Total 0.002092 11  
No post tests. P > 0.05    
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Appendix V RESULTS OF NON-PARAMETRIC TEST FOR 
IMMUNOSTAINING DATA OF A2B5 AND O4 AT 2DM 
 
Kruskal-Wallis test of A2B5+ve% in 2DM 
  P value P<0.0001  
  Exact or approximate P value? Gaussian 
Approximation 
 
Do the medians vary significant (P < 0.05) Yes  
  Number of groups 4  
  Kruskal-Wallis statistic 21.22  
Dunn's multiple comparison test Difference in rank sum P value 
  C-2DM-D vs C-2DM-N 6.276 P > 0.05 
  C-2DM-D vs S-2DM-D -7.187 P > 0.05 
  C-2DM-D vs S-2DM-N -39.12 P < 0.01 
  C-2DM-N vs S-2DM-D -13.46 P > 0.05 
  C-2DM-N vs S-2DM-N -45.39 P < 0.001 
  S-2DM-D vs S-2DM-N -31.93 P < 0.05 
 
 
Kruskal-Wallis test of O4+ve% in 2DM 
  P value 0.3526 
  Exact or approximate P value? Gaussian Approximation 
  P value summary ns 
Do the medians vary significant (P < 0.05) No 
  Number of groups 4 
  Kruskal-Wallis statistic 3.264 
No post tests. P > 0.05  
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Appendix VI RESULTS OF NON-PARAMETRIC TEST FOR      
IMMUNOSTAINING DATA OF A2B5, O4 AND GalC AT 3DM 
 
 
Kruskal-Wallis test of A2B5+ve% at 3DM 
  P value P<0.0001  
  Exact or approximate P value? Gaussian 
Approximation 
 
  P value summary ***  
Do the medians vary significant (P < 0.05) Yes  
  Number of groups 4  
  Kruskal-Wallis statistic 56.93  
Dunn's multiple comparison test Difference in rank sum P value 
  C-3DM-D vs C-3DM-N 4.831 P > 0.05 
  C-3DM-D vs S-3DM-D -46.55 P < 0.001 
  C-3DM-D vs S-3DM-N -60.4 P < 0.001 
  C-3DM-N vs S-3DM-D -51.38 P < 0.001 
  C-3DM-N vs S-3DM-N -65.23 P < 0.001 
  S-3DM-D vs S-3DM-N -13.86 P > 0.05 
 
 
 
 
Kruskal-Wallis test of O4+ve% at 3DM 
  P value 0.3325 
  Exact or approximate P value? Gaussian Approximation 
  P value summary ns 
Do the medians vary significant (P < 0.05) No 
  Number of groups 4 
  Kruskal-Wallis statistic 3.411 
No post tests. P > 0.05  
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Kruskal-Wallis test of GalC+ve% at 3DM 
  P value P<0.0001  
  Exact or approximate P value? Gaussian 
Approximation 
 
  P value summary ***  
Do the medians vary significant (P < 0.05) Yes  
  Number of groups 4  
  Kruskal-Wallis statistic 35.07  
Dunn's multiple comparison test Difference in rank sum P value 
  C-3DM-D vs C-3DM-N -3.319 P > 0.05 
  C-3DM-D vs S-3DM-D 39.94 P < 0.001 
  C-3DM-D vs S-3DM-N 47.11 P < 0.001 
  C-3DM-N vs S-3DM-D 43.26 P < 0.001 
  C-3DM-N vs S-3DM-N 50.43 P < 0.001 
  S-3DM-D vs S-3DM-N 7.171 P > 0.05 
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Appendix VII RESULTS OF ONE WAY ANOVA TEST 
FOR RT-PCR DATA OF CGT mRNA 
 
One-way analysis of variance of CGT transcription at GM 
  P value 0.0018  
  Are means signif. different? (P < 0.05) Yes  
  Number of groups 4  
Tukey's Multiple Comparison Test Mean Diff. P value 
  CG4-Dox vs CG4-No Dox 0 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-Dox 0.01667 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-No Dox 0.08 P < 0.01 
  CG4-No Dox vs CG4-SHoxa2-Dox 0.01667 P > 0.05 
  CG4-No Dox vs CG4-SHoxa2-No Dox 0.08 P < 0.01 
  CG4-SHoxa2-Dox vs CG4-SHoxa2-No Dox 0.06333 P < 0.05 
One-way analysis of variance of CGT transcription at 2DM 
  P value P<0.0001  
  Are means signif. different? (P < 0.05) Yes  
  Number of groups 4  
Tukey's Multiple Comparison Test Mean Diff. P value 
  CG4-Dox vs CG4-No Dox 0.003333 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-Dox 0.03 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-No Dox 0.1433 P < 0.001 
  CG4-No Dox vs CG4-SHoxa2-Dox 0.02667 P > 0.05 
  CG4-No Dox vs CG4-SHoxa2-No Dox 0.14 P < 0.001 
  CG4-SHoxa2-Dox vs CG4-SHoxa2-No Dox 0.1133 P < 0.001 
One-way analysis of variance of CGT transcription at 3DM 
  P value 0.0002  
  Are means signif. different? (P < 0.05) Yes  
  Number of groups 4  
Tukey's Multiple Comparison Test Mean Diff. P value 
  CG4-Dox vs CG4-No Dox 0.006667 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-Dox 0.04 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-No Dox -0.07667 P < 0.01 
  CG4-No Dox vs CG4-SHoxa2-Dox 0.03333 P > 0.05 
  CG4-No Dox vs CG4-SHoxa2-No Dox -0.08333 P < 0.01 
  CG4-SHoxa2-Dox vs CG4-SHoxa2-No Dox -0.1167 P < 0.001 
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Appendix VIII RESULTS OF ONE WAY ANOVA TEST 
FOR RT-PCR DATA OF MBP mRNA 
 
One-way analysis of variance of MBP transcription at GM 
  P value 0.0002  
  Are means signif. different? (P < 0.05) Yes  
  Number of groups 4  
Tukey's Multiple Comparison Test Mean Diff. P value 
  CG4-Dox vs CG4-No Dox -0.006667 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-Dox 0.1 P < 0.05 
  CG4-Dox vs CG4-SHoxa2-No Dox 0.17 P < 0.001 
  CG4-No Dox vs CG4-SHoxa2-Dox 0.1067 P < 0.01 
  CG4-No Dox vs CG4-SHoxa2-No Dox 0.1767 P < 0.001 
  CG4-SHoxa2-Dox vs CG4-SHoxa2-No Dox 0.07 P > 0.05 
One-way analysis of variance of MBP transcription at 2DM 
  P value 0.002  
  Are means signif. different? (P < 0.05) Yes  
  Number of groups 4  
Tukey's Multiple Comparison Test Mean Diff. P value 
  CG4-Dox vs CG4-No Dox -0.02333 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-Dox 0.02333 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-No Dox 0.12 P < 0.01 
  CG4-No Dox vs CG4-SHoxa2-Dox 0.04667 P > 0.05 
  CG4-No Dox vs CG4-SHoxa2-No Dox 0.1433 P < 0.01 
  CG4-SHoxa2-Dox vs CG4-SHoxa2-No Dox 0.09667 P < 0.05 
One-way analysis of variance of MBP transcription at 3DM 
  P value 0.0007  
  Are means signif. different? (P < 0.05) Yes  
  Number of groups 4  
Tukey's Multiple Comparison Test Mean Diff. P value 
  CG4-Dox vs CG4-No Dox -0.006667 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-Dox 0.02333 P > 0.05 
  CG4-Dox vs CG4-SHoxa2-No Dox 0.1417 P < 0.001 
  CG4-No Dox vs CG4-SHoxa2-Dox 0.03 P > 0.05 
  CG4-No Dox vs CG4-SHoxa2-No Dox 0.1483 P < 0.001 
  CG4-SHoxa2-Dox vs CG4-SHoxa2-No Dox 0.1183 P < 0.01 
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APPENDIX IX  ALIGNMENT OF SEQUENCING DATA OF 
pTRE2hyg2-Myc-SHoxa2 PLASMID WITH Hoxa2 cDNA 
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Note: Hoxa2-cDNA119 sequence information was obtained from GenBank (NM 010451). 
          SHoxa2-For represents sequence data from the 5' end, whereas SHoxa2-Rev 
represents sequence data from the 3' end.   
